Louis L. Pisters, M.D.

Peer-Reviewed Articles

1. Ratcliff, CG, Semelsberger, R, Matin, S, Tannir, NM, Jonasch, E, Pisters, LL, Cohen, L. Sex differences in the association of emotional approach coping with stress and quality of life among patients with renal cell carcinoma. Palliative and Supportive Care 24, 2026. e-Pub 2026. PMID: 41612823.
2. Zurita-Saavedra, A, Tidwell, R, Chapin, BF, Harris, DR, Zhang, M, Pisters, LL, Aparicio, A, Araujo, JC, Arce-Gallego, S, Zhu, K, Lozano, ML, Pagliaro, LC, Mateo, J, Logothetis, CJ, Troncoso, P, Davis, JW. Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis. European Urology Oncology 8(4):1010-1019, 2025. e-Pub 2025. PMID: 40651932.
3. Jackson, J, Sanchez, D, Joon, A, Estecio, MR, Johns, AC, Shah, AY, Campbell, M, Ward, JF, Pisters, LL, Guo, CC, Zhang, M, Millward, NZ, Tu, S. Bilateral Germ Cell Tumor of the Testis. Cells 14(9), 2025. e-Pub 2025. PMID: 40358182.
4. Evmorfopoulos, K, Vlachostergios, PJ, Chasiotis, G, Karatzas, A, Zachos, I, Koukoulis, GK, Dimitropoulos, K, Pisters, LL, Tzortzis, V. Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer at a National Referral Centre. Cancers 17(4), 2025. e-Pub 2025. PMID: 40002203.
5. Tabet, GC, Zheng, L, Hosseini, H, Ward, JF, Pisters, LL, Campbell, M, Tu, S, Czerniak, BA, Guo, CC. Epithelioid trophoblastic tumor in male patients with germ cell tumor. Human Pathology 153, 2024. e-Pub 2024. PMID: 39461379.
6. Patel, SA, Patil, D, Smith, JA, Saigal, C, Litwin, M, Hu, JC, Cooperberg, MR, Carroll, PR, Klein, EA, Kibel, AS, Andriole, GL, Han, M, Michalski, J, Wood, DP, Hembroff, L, Spratt, DE, Wei, JT, Sandler, H, Hamstra, DA, Pisters, LL, Kuban, DA, Regan, MM, Wagner, A, Crociani, C, Kaplan, I, Sanda, MG, Chang, P. Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life. JAMA Network Open 7(10), 2024. e-Pub 2024. PMID: 39446326.
7. Hahn, AW, Manyam, GC, Chapin, BF, Zhang, M, Yu, Y, Pettaway, CA, Chery, LJ, Pisters, LL, Ward, JF, Gregg, JR, Papadopoulos, JN, Kamat, A, Lozano, M, Hoang, A, Broom, BM, Wang, X, Huff, C, Logothetis, CJ, Troncoso, P, Pilie, PG, Davis, JW. A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates. BJU international 134(3):449-458, 2024. e-Pub 2024. PMID: 38837608.
8. Jackson, J, Sanchez, D, Johns, AC, Campbell, M, Aydin, AM, Gokden, N, Maraboyina, S, Muesse, JL, Ward, JF, Pisters, LL, Millward, NZ, Guo, C, Tu, S. Germ Cell Tumor of the Testis. Journal of Clinical Medicine 13(12), 2024. e-Pub 2024. PMID: 38929965.
9. Anselmino, N, Labanca, E, Shepherd, P, Dong, J, Yang, J, Song, X, Nandakumar, S, Kundra, R, Lee, CJ, Schultz, N, Zhang, J, Araujo, JC, Aparicio, A, Subudhi, SK, Corn, P, Pisters, LL, Ward, JF, Davis, JW, Vazquez, ES, Gueron, G, Logothetis, CJ, Futreal, A, Troncoso, P, Chen, Y, Navone, NM. Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series. Clinical Cancer Research 30(10):2272-2285, 2024. e-Pub 2024. PMID: 38488813.
10. Gregg, JR, Magill, RG, Fang, AM, Chapin, BF, Davis, JW, Adibi, M, Chery, LJ, Papadopoulos, JN, Pettaway, CA, Pisters, LL, Ward, J, Hahn, AW, Daniel-MacDougall, CR, Bhaskaran, J, Zhu, K, Guerrero, M, Zhang, M, Troncoso, P. The association of body mass index with tumor aggression among men undergoing radical prostatectomy. Urologic Oncology: Seminars and Original Investigations 42(4):116.e1-116.e7, 2024. e-Pub 2024. PMID: 38262868.
11. Singh, J, Wang, L, Smith III, T, Graber, WJ, Matin, S, Pisters, LL, Lenaine Westney, O. Ileal Interposition for Ureteral Reconstruction Following Treatment for Abdominopelvic Malignancy. Urology 183:215-220, 2024. e-Pub 2024. PMID: 37802194.
12. Dimitropoulos, K, Pisters, LL, Papandreou, CN, Daliani, D, Karatzas, A, Petsiti, A, Tassoudis, V, Arnaoutoglou, E, Vlachostergios, PJ, Tzortzis, V. The Impact of Enhanced Recovery after Surgery Protocol Implementation on Postoperative Pain Management in the Era of Opioid Crisis. Current cancer drug targets 23(11):910-916, 2023. e-Pub 2023. PMID: 37170984.
13. Moore JA, Lehner MJ, Anfossi S, Datar S, Tidwell RS, Campbell M, Shah AY, Ward JF, Karam JA, Wood CG, Pisters LL, Calin GA, Tu SM. Predictive capacity of a miRNA panel in identifying teratoma in post-chemotherapy consolidation surgeries. BJUI Compass 4(1):81-87, 2023. e-Pub 2023. PMID: 36569509.
14. Westerman, ME, Bree, KK, Msaouel, P, Kukreja, JB, Mantaring, C, Rukundo, I, Gonzalez, MG, Gregg, JR, Casteel, KN, Matin, S, Lafleur, AD, Best, RN, Crump, LD, Cunningham, JM, Saucedo, MA, Valle, DD, Varghese, R, Adibi, M, Chapin, BF, Chery, LJ, Davis, JW, Dinney, CP, Graber, WJ, Kamat, A, Karam, JA, Navai, N, Papadopoulos, JN, Pettaway, CA, Pisters, LL, Smith III, T, Ward, JF, Westney, OL, Wood, CG. Apixaban vs Enoxaparin for Post-Surgical Extended-Duration Venous Thromboembolic Event Prophylaxis. Journal of Urology 208(4):886-895, 2022. e-Pub 2022. PMID: 36082549.
15. Tu SM, Singh SR, Arnaoutakis K, Malapati S, Bhatti SA, Joon AY, Atiq OT, Pisters LL. Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench. Cancers (Basel) 14(14), 2022. e-Pub 2022. PMID: 35884406.
16. Moore JA, Slack RS, Lehner MJ, Campbell MT, Shah AY, Zhang M, Guo CC, Ward JF, Karam JA, Wood CG, Pisters LL, Tu SM. Very Late Recurrence in Germ Cell Tumor of the Testis: Lessons and Implications. Cancers (Basel) 14(5), 2022. e-Pub 2022. PMID: 35267435.
17. Mustafa, MO, Ward, JF, Davis, JW, Pettaway, CA, Pisters, LL. Transperineal saturation prostate biopsy in treated and untreated patients. Palestinian Medical and Pharmaceutical Journal 5(2):117-124, 2022. e-Pub 2022.
18. Hwang MJ, Hamza A, Zhang M, Tu SM, Pisters LL, Czerniak B, Guo CC. Somatic-type Malignancies in Testicular Germ Cell Tumors: A Clinicopathologic Study of 63 Cases. Am J Surg Pathol 46(1):11-17, 2022. e-Pub 2022. PMID: 34334690.
19. Alhalabi O, Campbell MT, Xiao L, Adriazola AC, Wilson NR, Siefker-Radtke AO, Corn PG, Zurita A, Jonasch E, Gao J, Adibi M, Kamat AM, Navai N, Pisters LL, Dinney C, Matin SF, Shah AY. Multimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinoma. BJUI Compass 3(1):37-44, 2022. e-Pub 2022. PMID: 35475152.
20. Westerman ME, Yevich SM, Dori Y, Ward JF, Pisters LL, Karam JA, Wood CG, Avritscher R, Matin SF. Lymphangioembolization for iatrogenic chylous ascites after retroperitoneal urologic surgery. BJU Int. e-Pub 2021. PMID: 34962705.
21. Asaad M, Pisters LL, Klein GT, Adelman DM, Oates SD, Butler CE, Selber JC. Robotic Rectus Abdominis Muscle Flap following Robotic Extirpative Surgery. Plast Reconstr Surg 148(6):1377-1381, 2021. e-Pub 2021. PMID: 34847128.
22. Pisters, PW, Ranasinghe, WK, Wei, W, Wood, CG, Matin, S, Ward, JF, Pisters, LL. Long-term renal functional outcomes following ureteroureterostomy performed during multi-organ resection for non-urothelial cancers. BJUI Compass 2(5):348-354, 2021. e-Pub 2021. PMID: 35474874.
23. Chin, J, Lavi, A, Metcalfe, MJ, Siddiqui, K, Dewar, M, Petros, FG, Li, R, Nogueras Gonzalez, G, Wang, X, Nair, SM, Ward, JF, Pisters, LL. Long-Term Outcomes of Whole Gland Salvage Cryotherapy for Locally Recurrent Prostate Cancer following Radiation Therapy. Journal of Urology 206(3):646-654, 2021. e-Pub 2021. PMID: 33908799.
24. Bozkurt Y, Atar M, Pisters LL. Early Experience with Salvage Robotic-Assisted Radical Prostatectomy in Proton Beam Radiotherapy Failures. Balkan Med J 38(5):310-315, 2021. e-Pub 2021. PMID: 34462255.
25. Tu SM, Zhang M, Wood CG, Pisters LL. Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity. Cancers (Basel) 13(16), 2021. e-Pub 2021. PMID: 34439162.
26. Sharma V, Miest TS, Juvet TS, Toussi A, Packiam V, Chamie K, Matin SF, Boorjian SA, Thompson RH, Frank I, Tollefson MK, Potretzke AM. Reply by Authors. J Urol:101097JU000000000000183402. e-Pub 2021. PMID: 34121427.
27. Ranasinghe W, Shapiro DD, Zhang M, Bathala T, Navone N, Thompson TC, Broom B, Aparicio A, Tu SM, Tang C, Davis JW, Pisters L, Chapin BF. Optimizing the diagnosis and management of ductal prostate cancer. Nat Rev Urol, 2021. e-Pub 2021.
28. Tu SM, Pisters LL. Curing Cancer: Lessons from a Prototype. Cancers (Basel) 13(4), 2021. e-Pub 2021. PMID: 33562202.
29. Ranasinghe W, Shapiro DD, Hwang H, Wang X, Reichard CA, Elsheshtawi M, Achim MF, Bathala T, Tang C, Aparicio A, Tu SM, Navone N, Thompson TC, Pisters L, Troncoso P, Davis JW, Chapin BF. Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies. Eur Urol 79(2):298-306, 2021. e-Pub 2021. PMID: 33279304.
30. Gregg JR, Borregales LD, Choi H, Lozano M, McRae SE, Venkatesan AM, Davis JW, Nogueras-Gonzalez GM, Pisters LL, Ward JF. Prospective trial of regional (hockey-stick) prostate cryoablation: oncologic and quality of life outcomes. World J Urol. e-Pub 2021. PMID: 33454813.
31. Umbreit EC, Siddiqui BA, Hwang MJ, Joon AY, Maity T, Westerman ME, Merriman KW, Alhasson H, Uthup J, Guo T, Moore JA, Ward JF, Karam JA, Wood CG, Pisters LL, Zhang M, Tu SM. Origin of Subsequent Malignant Neoplasms in Patients with History of Testicular Germ Cell Tumor. Cancers (Basel) 12(12), 2020. e-Pub 2020. PMID: 33327406.
32. Umbreit EC, McIntosh AG, Suk-Ouichai C, Segarra LA, Holland LC, Fellman BM, Williams SB, Thomas AZ, Tu SM, Pettaway CA, Pisters LL, Ward JF, Wood CG, Karam JA. Intraoperative and early postoperative complications in postchemotherapy retroperitoneal lymphadenectomy among patients with germ cell tumors using validated grading classifications. Cancer. e-Pub 2020. PMID: 32940929.
33. Palanisamy N, Yang J, Shepherd PDA, Li-Ning-Tapia EM, Labanca E, Manyam GC, Ravoori MK, Kundra V, Araujo JC, Efstathiou E, Pisters LL, Wan X, Wang X, Vazquez ES, Aparicio AM, Carskadon SL, Tomlins SA, Kunju LP, Chinnaiyan AM, Broom BM, Logothetis CJ, Troncoso P, Navone NM. The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development. Clin Cancer Res 26(18):4933-4946, 2020. e-Pub 2020. PMID: 32576626.
34. Ranasinghe WKB, Brooks NA, Elsheshtawi MA, Davis JW, Bathala TK, Tang C, Troncoso P, Aparicio A, Tu SM, Pisters LL, Chapin BF. Patterns of metastases of prostatic ductal adenocarcinoma. Cancer 126(16):3667-3673, 2020. e-Pub 2020. PMID: 32453443.
35. Gregg JR, Davis JW, Reichard C, Wang X, Achim M, Chapin BF, Pisters L, Pettaway C, Ward JF, Choi S, Nguyen QN, Kuban D, Babaian R, Troncoso P, Madsen LT, Logothetis C, Kim J. Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance Cohort. Urology 138:91-97, 2020. e-Pub 2020. PMID: 31899230.
36. Narayan VM, Seif MA, Lim AH, Li R, Matulay JT, Kukreja JB, Qiao W, Hwang H, Shah JB, Pisters L, Kamat AM, Dinney C, Navai N. Radical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomes. Urol Oncol 38(4):247-254, 2020. e-Pub 2020. PMID: 31953001.
37. Subudhi SK, Vence L, Zhao H, Blando J, Yadav SS, Xiong Q, Reuben A, Aparicio A, Corn PG, Chapin BF, Pisters LL, Troncoso P, Tidwell RS, Thall P, Wu CJ, Zhang J, Logothetis CL, Futreal A, Allison JP, Sharma P. Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer. Sci Transl Med 12(537), 2020. e-Pub 2020. PMID: 32238575.
38. Li R, Kukreja JEB, Seif MA, Petros FG, Campbell MT, Nguyen JV, González GMN, Kamat AM, Pisters LL, Dinney CP, Navai N. The role of metastatic burden in cytoreductive/consolidative radical cystectomy. World J Urol 37(12):2691-2698, 2019. e-Pub 2019. PMID: 30864005.
39. Ho L, Pisters L, Tu SM. Rapidly enlarging abdominal mass in a patient with recurrent germ cell tumor. Clin Case Rep 7(11):2285-2286, 2019. e-Pub 2019. PMID: 31788307.
40. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Corn P, Logothetis C, Ward J, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, Kuban DA. Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends. Cancer. e-Pub 2019. PMID: 31742674.
41. Efstathiou E, Davis JW, Pisters L, Li W, Wen S, McMullin RP, Gormley M, Ricci D, Titus M, Hoang A, Zurita AJ, Tran N, Peng W, Kheoh T, Molina A, Troncoso P, Logothetis CJ. Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone. Eur Urol 76(4):418-424, 2019. e-Pub 2019. PMID: 31176622.
42. Altok M, Kim B, Patel BB, Shih YT, Ward JF, McRae SE, Chapin BF, Pisters LL, Pettaway CA, Kim J, Demirel HC, Davis JW. Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research. Prostate Cancer Prostatic Dis 21(4):524-532, 2018. e-Pub 2018. PMID: 29988098.
43. Karatzas, A, Papadopoulos, V, Katsiouli, V, Pisters, LL, Papandreou, CN, Tzortzis, V. Primitive neuroectodermal tumor transformation of testicular teratoma. Urology Annals 10(4):413-415, 2018. e-Pub 2018. PMID: 30386097.
44. Chahoud J, Zhang M, Pisters LL, Lin SC, Lin SH, Tu SM. Identification of Glypican-3 (GPC3) Expression in a Lethal Subgroup of Refractory Cisplatin-Resistant Testicular Germ-Cell Tumors. Clin Genitourin Cancer 16(5):325-327, 2018. e-Pub 2018. PMID: 29807831.
45. Reichard CA, Gregg JR, Achim MF, Aparicio AM, Pettaway CA, Pisters LL, Ward JF, Davis JW, Chapin BF. Radical Prostatectomy in Metastatic Castration-resistant Prostate Cancer: Feasibility, Safety, and Quality of Life Outcomes. Eur Urol 74(2):140-143, 2018. e-Pub 2018. PMID: 29656854.
46. Chahoud J, Zhang M, Shah A, Lin SH, Pisters LL, Tu SM. Managing seminomatous and nonseminomatous germ cell tumors. Curr Opin Oncol 30(3):181-188, 2018. e-Pub 2018. PMID: 29538040.
47. Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, Nguyen Q, Mahmood U, Graber WJ, Chen HC, Wang X, Kuban DA. Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort. BJU Int 121(4):540-548, 2018. e-Pub 2018. PMID: 28941030.
48. Basourakos SP, Davis JW, Chapin BF, Ward JF, Pettaway CA, Pisters LL, Navai N, Achim MF, Wang X, Chen HC, Choi S, Kuban D, Troncoso P, Hanash S, Thompson TC, Kim J. Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer. BJU Int 121(1):69-76, 2018. e-Pub 2018. PMID: 28710901.
49. Milbury K, Lopez G, Spelman A, Wood C, Matin SF, Tannir NM, Jonasch E, Pisters L, Wei Q, Cohen L. Examination of moderators of expressive writing in patients with renal cell carcinoma: the role of depression and social support. Psychooncology 26(9):1361-1368, 2017. e-Pub 2017. PMID: 27145447.
50. Cox M, Basen-Engquist K, Carmack CL, Blalock J, Li Y, Murray J, Pisters L, Rodriguez-Bigas M, Song J, Cox-Martin E, Demark-Wahnefried W. Comparison of Internet and Telephone Interventions for Weight Loss Among Cancer Survivors: Randomized Controlled Trial and Feasibility Study. JMIR Cancer 3(2):e16, 2017. e-Pub 2017. PMID: 28954716.
51. Metcalfe MJ, Troncoso P, Guo CC, Chen HC, Bozkurt Y, Ward JF, Pisters LL. Salvage prostatectomy for post-radiation adenocarcinoma with treatment effect: Pathological and oncological outcomes. Can Urol Assoc J 11(7):E277-E284, 2017. e-Pub 2017. PMID: 28761588.
52. Gay, HA, Sanda, MG, Liu, J, Wu, N, Hamstra, DA, Wei, JT, Dunn, RL, Klein, EA, Sandler, H, Saigal, C, Litwin, M, Kuban, DA, Hembroff, L, Regan, MM, Chang, P, Northouse, L, Wood, DP, Ciezki, J, Michalski, J, Andriole, GL, Greenfield, TK, Pisters, LL, Hu, JC, Kibel, AS, Dahl, DM, Zietman, AL, Kaplan, I, Wagner, A. External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy. International Journal of Radiation Oncology Biology Physics 98(2):304-317, 2017. e-Pub 2017. PMID: 28463150.
53. Malakorn S, Sammour T, Pisters LL, Chang GJ. Robotic Total Pelvic Exenteration. Dis Colon Rectum 60(5):555, 2017. e-Pub 2017. PMID: 28383456.
54. Fernández MI, Williams SB, Willis DL, Slack RS, Dickstein RJ, Parikh S, Chiong E, Siefker-Radtke AO, Guo CC, Czerniak BA, McConkey DJ, Shah JB, Pisters LL, Grossman HB, Dinney CP, Kamat AM. Clinical Risk Stratification in Patients with Surgically Resectable Micropapillary Bladder Cancer. BJU Int 119(5):684-691, 2017. e-Pub 2017. PMID: 27753185.
55. Pham MN, Apolo AB, De Santis M, Galsky MD, Leibovich BC, Pisters LL, Siefker-Radtke AO, Sonpavde G, Steinberg GD, Sternberg CN, Tagawa ST, Weizer AZ, Woods ME, Milowsky MI. Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer. World J Urol 35(3):367-378, 2017. e-Pub 2017. PMID: 27342991.
56. Mustafa M, Davis JW, Gorgel SN, Pisters L. Robotic or Open Radical Prostatectomy in Men with Previous Transurethral Resection of Prostate, 2017. e-Pub 2017. PMID: 28116739.
57. Bilen MA, Hess KR, Campbell MT, Wang J, Broaddus RR, Karam JA, Ward JF, Wood CG, Choi SL, Rao P, Zhang M, Naing A, General R, Cauley DH, Lin SH, Logothetis CJ, Pisters LL, Tu SM. Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis. Oncotarget 7(52):86280-86289, 2016. e-Pub 2016. PMID: 27861143.
58. Davis JW, Ward JF, Pettaway CA, Wang X, Kuban D, Frank SJ, Lee AK, Pisters LL, Matin SF, Shah JB, Karam JA, Chapin BF, Papadopoulos JN, Achim M, Hoffman KE, Pugh TJ, Choi S, Troncoso P, Logothetis CJ, Kim J. Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int 118(1):68-76, 2016. e-Pub 2016. PMID: 26059275.
59. Tu SM, Bilen MA, Hess KR, Broaddus RR, Kopetz S, Wei C, Pagliaro LC, Karam JA, Ward JF, Wood CG, Rao P, Tu ZH, General R, Chen AH, Nieto YL, Yeung SC, Lin SH, Logothetis CJ, Pisters LL. Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer. Cancer 122(12):1836-43, 2016. e-Pub 2016. PMID: 27018785.
60. Kenney PA, Nawaf CB, Mustafa M, Wen S, Wszolek MF, Pettaway CA, Ward JF, Davis JW, Pisters LL. Robotic-assisted laparoscopic versus open salvage radical prostatectomy following radiotherapy. Can J Urol 23(3):8271-7, 2016. e-Pub 2016. PMID: 27347619.
61. Kim J, Davis JW, Klein EA, Magi-Galluzzi C, Lotan Y, Ward JF, Pisters LL, Basler JW, Pettaway CA, Stephenson A, Li Ning Tapia EM, Efstathiou E, Wang X, Do KA, Lee JJ, Gorlov IP, Vornik LA, Hoque AM, Prokhorova IN, Parnes HL, Lippman SM, Thompson IM, Brown PH, Logothetis CJ, Troncoso P. Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer. EBioMedicine 7:85-93, 2016. e-Pub 2016. PMID: 27322462.
62. Ho PL, Willis DL, Patil J, Xiao L, Williams SB, Melquist JJ, Tart K, Parikh S, Shah JB, Delacroix SE, Navai N, Siefker-Radtke A, Dinney CP, Pisters LL, Kamat AM. Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience. Urol Oncol 34(2):59.e1-8, 2016. e-Pub 2016. PMID: 26421586.
63. Thekdi SM, Milbury K, Spelman A, Wei Q, Wood C, Matin SF, Tannir N, Jonasch E, Pisters L, Cohen L. Posttraumatic stress and depressive symptoms in renal cell carcinoma: association with quality of life and utility of single-item distress screening. Psychooncology 24(11):1477-84, 2015. e-Pub 2015. PMID: 25690556.
64. Williams SB, Davis JW, Wang X, Achim MF, Zurita-Saavedra A, Matin SF, Pisters LL, Ward JF, Pettaway CA, Chapin BF. Neoadjuvant Systemic Therapy Before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity: Contemporary Results Using the Clavien System. Clin Genitourin Cancer. e-Pub 2015. PMID: 26558524.
65. Zurita AJ, Pisters LL, Wang X, Troncoso P, Dieringer P, Ward JF, Davis JW, Pettaway CA, Logothetis CJ, Pagliaro LC. Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancer. Prostate Cancer Prostatic Dis 18(3):276-80, 2015. e-Pub 2015. PMID: 26171883.
66. Dimitropoulos K, Karatzas A, Papandreou C, Daliani D, Zachos I, Pisters LL, Tzortzis V. Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: a focus beyond ejaculation disorders. Andrologia. e-Pub 2015. PMID: 26268684.
67. Merrill MM, Wood CG, Tannir NM, Slack RS, Babaian KN, Jonasch E, Pagliaro LC, Compton Z, Tamboli P, Sircar K, Pisters LL, Matin SF, Karam JA. Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent. Urol Oncol 33(4):166.e21-9, 2015. e-Pub 2015. PMID: 25700975.
68. Willis DL, Fernandez MI, Dickstein RJ, Parikh S, Shah JB, Pisters LL, Guo CC, Henderson S, Czerniak BA, Grossman HB, Dinney CP, Kamat AM. Clinical outcomes of cT1 micropapillary bladder cancer. J Urol 193(4):1129-34, 2015. e-Pub 2015. PMID: 25254936.
69. Prinsloo S, Wei Q, Scott SM, Tannir N, Jonasch E, Pisters L, Cohen L. Psychological states, serum markers and survival: associations and predictors of survival in patients with renal cell carcinoma. J Behav Med 38(1):48-56, 2015. e-Pub 2015. PMID: 24935017.
70. Mustafa M, Pisters LL. Emergency robotic radical prostatectomy for acute prostate radiation overdose. The New Journal of Urology 10(2):49-51, 2015. e-Pub 2015.
71. Mustafa M, Pettaway CA, Davis JW, Pisters L. Robotic or open radical prostatectomy after previous open surgery in the pelvic region. Korean J Urol 56(2):131-7, 2015. e-Pub 2015. PMID: 25685300.
72. Mustafa M, Delacroix S, Ward JF, Pisters L. The feasibility and safety of repeat cryosurgical ablation of localized prostate cancer. World J Surg Oncol 13:340, 2015. e-Pub 2015. PMID: 26691335.
73. Mustafa M, Pisters L. Emergency robotic radical prostatectomy for acute prostate radiation overdose. The New Journal of Urology 10(2):49-51, 2015. e-Pub 2015.
74. Bilen MA, Reyes A, Bhowmick D, Maa A, Bast R, Pisters LL, Lin SH, Logothetis CJ, Tu SM. Variant prostate carcinoma and elevated serum CA-125. Can J Urol 21(5):7442-8, 2014. e-Pub 2014. PMID: 25347368.
75. Bilen MA, Hariri H, Leon C, Guo CC, Kuban DA, Pisters LL, Tu SM. Positive FDG-PET/CT scans of a residual seminoma after chemotherapy and radiotherapy: case report and review of the literature. Clin Genitourin Cancer 12(4):e147-50, 2014. e-Pub 2014. PMID: 24674785.
76. Madsen LT, Kuban DA, Choi S, Davis JW, Kim J, Lee AK, Domain D, Levy L, Pisters LL, Pettaway CA, Ward JF, Logothetis C, Hoffman KE. Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic. J Natl Compr Canc Netw 12(7):993-8, 2014. e-Pub 2014. PMID: 24994920.
77. Prinsloo S, Wei Q, Scott SM, Tannir N, Jonasch E, Pisters L, Cohen L. Psychological states, serum markers and survival: asociations and predictors of survival in patients with renal cell carcinoma. e-Pub 2014.
78. Gilbert, SM, Sanda, MG, Dunn, RL, Greenfield, TK, Hembroff, L, Klein, EA, Saigal, C, Pisters, LL, Michalski, J, Sandler, H, Litwin, M, Wei, JT. Satisfaction with information used to choose prostate cancer treatment. Journal of Urology 191(5):1265-1271, 2014. e-Pub 2014. PMID: 24333514.
79. Prensner JR, Chen W, Iyer MK, Cao Q, Ma T, Han S, Sahu A, Malik R, Wilder-Romans K, Navone N, Logothetis CJ, Araujo JC, Pisters LL, Tewari AK, Canman CE, Knudsen KE, Kitabayashi N, Rubin MA, Demichelis F, Lawrence TS, Chinnaiyan AM, Feng FY. PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer. Cancer Res 74(6):1651-60, 2014. e-Pub 2014. PMID: 24473064.
80. Milbury K, Spelman A, Wood C, Matin SF, Tannir N, Jonasch E, Pisters L, Wei Q, Cohen L. Randomized controlled trial of expressive writing for patients with renal cell carcinoma. J Clin Oncol 32(7):663-70, 2014. e-Pub 2014. PMID: 24470003.
81. Gibert SM, Sanda MG, Dunn RL, Greenfield K, Hembroff L, Klein E, Saigal CS, Pisters L, Michalski J, Sandler HM, Litwin MS, Wei JT. Satisfaction with information used to choose prostate cancer treatment, 2013. e-Pub 2013.
82. Speiss PE, Levy DA, Mouraviev V, Pisters LL, Jones JS. Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model. BJU Int 112(4), 2013. e-Pub 2013. PMID: 23469778.
83. Hamstra DA, Conlon AS, Daignault S, Dunn RL, Sandler HM, Hembroff AL, Zietman AL, Kaplan I, Ciezki J, Kuban DA, Wei JT, Sanda MG, Michalski JM, Study Group PC. Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience. Int J Radiat Oncol Biol Phys 86(3):546-53, 2013. e-Pub 2013. PMID: 23561651.
84. Matin SF, Cormier JN, Ward JF, Pisters, LL, Wood, CG, Dinney CPN, Royal RE, Huang X, Pettaway CA. Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma. BJU International 111(7), 2013. e-Pub 2013. PMID: 23551693.
85. Kazer MW, Bailey DE, Chipman J, Psutka SP, Hardy J, Hembroff L, Regan M, Dunn RL, Crociani C, Sanda MG, Study Group PC. Uncertainty and perception of danger among patients undergoing treatment for prostate cancer. BJU Int 111(3 Pt B):E84-91, 2013. e-Pub 2013. PMID: 22985348.
86. Efstathiou E, Karlou M, Wen S, Hoang A, Pettaway CA, Pisters LL, Maity S, Troncoso P, Logothetis CJ. Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers. Prostate 73(2), 2013. e-Pub 2013. PMID: 22753310.
87. Spiess PE, Levy DA, Pisters LL, Mouraviev V, Jones JS. Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: update from the COLD registry. World J Urol 2013 Dec;31. e-Pub 2012. PMID: 23179729.
88. Biegler, K, Cohen, L, Scott, SM, Hitzhusen, K, Parker, PA, Gilts, CD, Canada, AL, Pisters, LL. The role of religion and spirituality in psychological distress prior to surgery for urologic cancer. Integrative cancer therapies 11(3):212-220, 2012. e-Pub 2012. PMID: 21964511.
89. Som, A, Zhu, R, Guo, CC, Efstathiou, E, Xiao, L, Pisters, LL, Matin, A, Tu, S. Recurrent seminomas. Urologic Oncology: Seminars and Original Investigations 30(4):494-501, 2012. e-Pub 2012. PMID: 20822932.
90. Leibovici D, Chiong E, Pisters LL, Guo CC, Ward JF, Andino L, Prokhorova IN, Troncoso P. Pathological characteristics of prostate cancer recurrence after radiation therapy: implications for focal salvage therapy. J Urol 188(1):98-102, 2012. e-Pub 2012. PMID: 22578724.
91. Parker PA, Swartz R, Fellman B, Urbauer D, Li Y, Pisters LL, Rosser CJ, Wood CG, Matin SF. Comprehensive assessment of quality of life and psychosocial adjustment in patients with renal tumors undergoing open, laparoscopic and nephron sparing surgery. J Urol 187(3):822-6, 2012. e-Pub 2012. PMID: 22245327.
92. Okorie CO, Pisters LL. Modifying and increasing day-case procedures to solve local problems: Experience of a urology unit. Niger Med J 53(1):26-30, 2012. e-Pub 2012. PMID: 23271841.
93. Cohen L, Cole SW, Sood AK, Prinsloo S, Kirschbaum C, Arevalo JM, Jennings NB, Scott S, Vence L, Wei Q, Kentor D, Radvanyi L, Tannir N, Jonasch E, Tamboli P, Pisters L. Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling. PLoS One 7(8):e42324, 2012. e-Pub 2012. PMID: 22870317.
94. Alemozaffar, M, Regan, MM, Cooperberg, MR, Wei, JT, Michalski, J, Sandler, H, Hembroff, L, Sadetsky, N, Saigal, C, Litwin, M, Klein, EA, Kibel, AS, Hamstra, DA, Pisters, LL, Kuban, DA, Kaplan, I, Wood, DP, Ciezki, J, Dunn, RL, Carroll, PR, Sanda, MG. Prediction of erectile function following treatment for prostate cancer. JAMA 306(11):1205-1214, 2011. e-Pub 2011. PMID: 21934053.
95. Biegler K, Cohen L, Scott S, Hitzhusen K, Parker P, Gilts CD, Canada A, Pisters LL. The Role of Religion and Spirituality in Psychological Distress Prior to Surgery for Urologic Cancer. Integr Cancer Ther. e-Pub 2011.
96. Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, Kaplan ID, Wood DP, Ciezki J, Dunn RL, Carroll PR, Sanda MG. Prediction of erectile function following treatment for prostate cancer. JAMA 306(11):1205-14, 2011. e-Pub 2011.
97. Okorie CO, Pisters LL, Liu P. Longstanding hydrocele in adult Black Africans: Is preoperative scrotal ultrasound justified?. Niger Med J 52(3):173-6, 2011. e-Pub 2011. PMID: 22083049.
98. Okorie CO, Pisters LL, Liu P. Longstanding hydrocele in adult Black Africans: Is preoperative scrotal ultrasound justified?. Niger Med J 52(3):173-6, 2011. e-Pub 2011.
99. Tzelepi, V, Efstathiou, E, Wen, S, Troncoso, P, Karlou, M, Pettaway, CA, Pisters, LL, Hoang, A, Logothetis, CJ, Pagliaro, LC. Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment. Journal of Clinical Oncology 29(18):2574-2581, 2011. e-Pub 2011. PMID: 21606419.
100. Tzelepi V, Efstathiou E, Wen S, Troncoso P, Karlou M, Pettaway CA, Pisters LL, Hoang A, Logothesis CJ, Pagliaro LC. Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment. L Clin Oncol 29(18):2574-81, 2011. e-Pub 2011.
101. Wiegand, LR, Hernandez, M, Pisters, LL, Spiess, PE. Surgical management of lymph-node-positive prostate cancer. BJU international 107(8):1238-1242, 2011. e-Pub 2011. PMID: 20880197.
102. Cohen, L, Parker, PA, Vence, LM, Savary, C, Kentor, D, Pettaway, CA, Babaian, RJ, Pisters, LL, Miles, B, Wei, Q, Wiltz, L, Patel, T, Radvanyi, L. Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy. Psychosomatic medicine 73(3):218-225, 2011. e-Pub 2011. PMID: 21257977.
103. Cohen L, Parker PA, Vence L, Savary C, Kentor D, Pettaway CA, Babaian R, Pisters LL, Miles B, Wei Q, Wiltz L, Patel T, Radvanyi L. Presurfical Stress Management Improves Postoperative Immune Function in Men with Prostate Cancer Undergoing Radical Prostatectomy. Pyschosomatic Medicine 73(0):1-8, 2011. e-Pub 2011.
104. Levy, DA, Jones, JS. Prognostic value of initial prostate-specific antigen levels after salvage cryoablation for prostate cancer. BJU international 106(7):986-990, 2010. e-Pub 2010. PMID: 20230388.
105. Levy DA, Pisters LL, Jones JS. Prognostic Value of Initial Prostate-Specific Antigen Levels After Salvage Cryoablation for Prostate Cancer. BJU Int 106(7):986-990, 2010. e-Pub 2010.
106. Okorie, CO, Pisters, LL, Ndasi, HT, Fekadu, A. A simplified protocol for evaluating and monitoring urethral stricture patients minimizes cost without compromising patient outcome. International Braz J Urol 36(5):640, 2010. e-Pub 2010.
107. Sexton, WJ, Spiess, PE, Pisters, LL, Carpenter, S, Madsen, LT, Zagone, R, Wang, X, Troncoso, P. Are there differences in zonal distribution and tumor volume of prostate cancer in patients with a positive family history?. International Braz J Urol 36(5):571-581, 2010. e-Pub 2010. PMID: 21044374.
108. Wiegand LR, Hernandez M, Pisters LL, Spiess PE. Surgical Management of Lymph-Node Positive Prostate Cancer: Improves Symptomatic Control. BJU Int, 2010. e-Pub 2010.
109. Sexton WJ, Spiess PE, Pisters LL, Carpenter S, Madsen LT, Zagone R, Wang X, Troncoso P. Are There Differences in Zonal Distribution and Tumor Volume of Prostate Cancer in Patients with a Positive Family History?. J Urol 36(5):571-582, 2010. e-Pub 2010.
110. Som A, Zhu R, Guo CC, Efstathio E, Xiao L, Pisters LL, Matin A, Tu SM. Recurrent Seminomas: Clinical Features and Biologic Implications. Urol Oncol, 2010. e-Pub 2010.
111. Okorie CO, Pisters LL. Effect of Modified Suprapubic Prostatectomy for Benign Prostatic Hyoerplasia on Postoperative Hemoglobin Levels. Can J Urol 17(4):5255-5258, 2010. e-Pub 2010.
112. Zafirakis H, De EJ, Pisters LL, Pettaway C, Westney OL. Long-Term Outcomes and Patient Satisfaction of Continent Catheterizable Limb and Augmentation Cystoplasty Simultaneous with Salvage Prostatectomy. Neurourol Urodyn 29(Suppl 1):S51-56, 2010. e-Pub 2010.
113. Okorie, CO, Pisters, LL, Ndasi, HT, Fekadu, A. A simplified protocol for evaluating and monitoring urethral stricture patients minimizes cost without compromising patient outcome. Tropical Doctor 40(3):134-137, 2010. e-Pub 2010. PMID: 20413547.
114. Spiess, PE, Katz, AE, Chin, J, Bahn, D, Cohen, JK, Shinohara, K, Hernandez, M, Bossier, J, Kassouf, W, Pisters, LL. A pretreatment nomogram predicting biochemical failure after salvage cryotherapy for locally recurrent prostate cancer. BJU international 106(2):194-198, 2010. e-Pub 2010. PMID: 19922545.
115. Taylor, JM, Spiess, PE, Kassouf, W, Munsell, M, Kamat, A, Dinney, CP, Barton Grossman, H, Pisters, LL. Management of urethral recurrence after orthotopic urinary diversion. BJU international 106(1):56-61, 2010. e-Pub 2010. PMID: 20002676.
116. Contreras, A, Punar, M, Tamboli, P, Tu, S, Pisters, LL, Moran, C, Czerniak, BA, Guo, CC. Mediastinal germ cell tumors with an angiosarcomatous component. Human Pathology 41(6):832-837, 2010. e-Pub 2010. PMID: 20153508.
117. Efstathiou, E, Abrahams, NA, Tibbs, RF, Wang, X, Pettaway, CA, Pisters, LL, Mathew, P, Do, K, Logothetis, CJ, Troncoso, P. Morphologic Characterization of Preoperatively Treated Prostate Cancer. European urology 57(6):1030-1038, 2010. e-Pub 2010. PMID: 19853370.
118. Childs, MA, Wood, CG, Spiess, PE, Debiane, LG, Hernandez, M, Matin, S, Millikan, RE, Siefker-Radtke, AO, Scott, SM, Pisters, LL. Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy. Canadian Journal of Urology 17(3):5184-5189, 2010. e-Pub 2010. PMID: 20566011.
119. Childs MA, Wood CG, Spiess PE, Debiane LG, Hernandez M, Matin SF, Millikan RE, Siefker-Radtkie A, Scott SM, Pisters LL. Early Results of Chemotherapy with Retroperitoneal Lymph Node Dissection for Isolated Retroperitoneal Recurrence of Upper Urinary Tract Urothelial Carcinoma after Nephroureterectomy. Can J Urol 17(3):5184-5189, 2010. e-Pub 2010.
120. Shinn, EH, Swartz, RJ, Thornton, B, Spiess, PE, Pisters, LL, Basen-Engquist, KM. Testis cancer survivors' health behaviors. Journal of Clinical Oncology 28(13):2274-2279, 2010. e-Pub 2010. PMID: 20368572.
121. Shinn EH, Swartz RJ, Thornton BB, Spiess PE, Pisters LL, Basen-Engquist KM. Testis Cancer Survivor's Health Behaviors: Comparison with Age-Matched Relative and Demographically Matched Population Controls. J Clin Oncol 28(13):2274-2279, 2010. e-Pub 2010.
122. Pisters LL. Cryotherapy for Prostate Cancer: Ready for Prime Time?. Current Opinion in Urology 20:218-222, 2010. e-Pub 2010.
123. Okorie, CO, Pisters, LL. Monti reconstruction in patients with complex vesicovaginal fistula. Canadian Journal of Urology 17(2):5124-5126, 2010. e-Pub 2010. PMID: 20398454.
124. Davis, JW, Kamat, A, Munsell, M, Pettaway, CA, Pisters, LL, Matin, S. Initial experience of teaching robot-assisted radical prostatectomy to surgeons-in-training. BJU international 105(8):1148-1154, 2010. e-Pub 2010. PMID: 19874300.
125. Okorie CO, Pisters LL. Monti Reconstruction in Patients with Complex Vesicovaginal Fistula. Can J Urol 17(2):5124-5126, 2010. e-Pub 2010.
126. Okorie CO, Pisters LL, Ndasi HT, Fekadu A. A Simplified Protocol for Evaluating and Monitoring Urethral Stricture Patients Minimizes Cost Without Compromising Patient Outcome. Trop Doct 40(3):134-137, 2010. e-Pub 2010.
127. Okorie, CO, Salia, M, Liu, P, Pisters, LL. Modified Suprapubic Prostatectomy Without Irrigation Is Safe. Urology 75(3):701-705, 2010. e-Pub 2010. PMID: 19914705.
128. Chiong, E, Hegarty, PK, Davis, JW, Kamat, A, Pisters, LL, Matin, S. Port-site Hernias Occurring After the Use of Bladeless Radially Expanding Trocars. Urology 75(3):574-580, 2010. e-Pub 2010. PMID: 19854489.
129. Contreras AL, Punar M, Tamboli P, Tu SM, Pisters LL, Moran C, Czerniak BA, Guo CC. Mediastinal Germ Cell Tumors with an Angiosarcomatous Component: A Report of 12 Cases. Human Pathology 20(3):832-837, 2010. e-Pub 2010.
130. Zafirakis, H, De, EJ, Pisters, LL, Pettaway, CA, Westney, OL. Long-term outcomes and patient satisfaction of continent catheterizable limb and augmentation cystoplasty simultaneous with salvage prostatectomy. Neurourology and Urodynamics 29(SUPPL. 1):S51-S56, 2010. e-Pub 2010. PMID: 20419802.
131. Taylor JM, Spiess PE, Kassouf W, Munsell MF, Kamat AM, Dinney CP, Grossman HB, Pisters LL. Management of Urethral Recurrence After Orthotopic Urinary Diversion. BJU Int 106(1):56-61, 2009. e-Pub 2009.
132. Guo CC, Pisters LL, Troncoso P. Prostate Cancer Invading the Rectum: A clinicopathological Study of 18 Cases. Pathology 41(6):539-543, 2009. e-Pub 2009.
133. Spiess PE, Katz AE, Chin JL, Bahn D, Cohen JK, Shinohara K, Hernandez M, Bossier J, Kassouf W, Pisters LL. A Pretreatment Nomogram Predicting Biochemical Failure After Salvage Cryotherapy for Locally Recurrent Prostate Cancer. BJU Int 106(2):194-198, 2009. e-Pub 2009.
134. Okorie CO, Salia M, Liu P, Pisters LL. Modified Suprapubic Prostatectomy Without Irrigation is Safe. Urology 75(3):701-705, 2009. e-Pub 2009.
135. Davis JW, Kamat AM, Munsell M Pettaway CA, Pisters LL, Matin SF. Initial Experience of Teaching Robot-Assisted Radical Prostatectomy to Suregeons in- Training: Can Training be Evaluated and Standardized?. BJU Int, 2009. e-Pub 2009.
136. Efstathiou E, Abrahams NA, Tibbs RF, Wang X, Pettaway CA, Pisters LL, Mathew PF, Do KA, Logothetis CJ, Troncoso P. Morphologic Characterization of Preoperatively Treated Prostate Cancer: Toward a Post-Therapy Histologic Classification. Eur Urol 57(6):1030-1038, 2009. e-Pub 2009.
137. Chiong E, Hegarty PK, Davis JW, Kamat AM, Pisters LL, Matin SF. Port-site Hernias Occurring After the Use of Bladeless Radially Expanding Trocars. Urology 75(3):574-580, 2009. e-Pub 2009.
138. Levy, DA, Pisters, LL, Jones, JS. Primary Cryoablation Nadir Prostate Specific Antigen and Biochemical Failure. Journal of Urology 182(3):931-937, 2009. e-Pub 2009. PMID: 19616226.
139. Levy, DA, Pisters LL, Jones JS. Primary cryoablation nadir prostate specific antigen and biochemical failure. J Urol 182(3):931-7, 2009. e-Pub 2009.
140. Ward, JF, Nakanishi, H, Pisters, LL, Babaian, RJ, Troncoso, P. Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy. BJU international 104(4):490-497, 2009. e-Pub 2009. PMID: 19220260.
141. Guo, CC, Punar, M, Contreras, A, Tu, S, Pisters, LL, Tamboli, P, Czerniak, BA. Testicular germ cell tumors with sarcomatous components. American Journal of Surgical Pathology 33(8):1173-1178, 2009. e-Pub 2009. PMID: 19561445.
142. Pisters, LL, Leibovici, D, Blute, ML, Zincke, H, Sebo, TJ, Slezak, JM, Izawa, JI, Ward, JF, Scott, SM, Madsen, LT, Spiess, PE, Leibovich, BC. Locally Recurrent Prostate Cancer After Initial Radiation Therapy. Journal of Urology 182(2):517-527, 2009. e-Pub 2009. PMID: 19524984.
143. Ward JF, Nakanishi H, Pisters LL, Babaian RJ, Troncoso P. Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy. BJU Int 104(4):490-7, 2009. e-Pub 2009.
144. Raz O, Pisters LL, Spiess PE, Lindner A, Leibovici D. Palliative Surgery for Locally Advanced Prostate Cancer. Harefuah 148(8):535-538, 571, 2009. e-Pub 2009.
145. Davis, JW, Famat AM, Munsell M, Pettaway CA, Pisters, LL, Matin SF. Initial Experience Teaching Robot-Assisted Radical Prostatectomy to surgeons-in-training: Can Training be Evaluated and Standardized?. British Journal of Urology International, 2009. e-Pub 2009.
146. Guo CC, Punar M, Contreras AL, Tu SM, Pisters LL, Tamboli P Czerniak B. Testicular germ cell tumors with saracomatous components: an analysis of 33 cases. Am J Surg Pathol 33(8):1173-8, 2009. e-Pub 2009.
147. Pisters LL, Leibovic D, Blute M, Zincke H, Sebo TJ, Slezak JM, Izawa J, Ward JF, Scott SM, Madsen L, Spiess PE Leibovich BC. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. J Urol 182(2):517-25, 2009. e-Pub 2009.
148. Parker, PA, Pettaway, CA, Babaian, RJ, Pisters, LL, Miles, B, Fortier, A, Wei, Q, Carr, DD, Cohen, L. The effects of a presurgical stress management intervention for men with prostate cancer undergoing radical prostatectomy. Journal of Clinical Oncology 27(19):3169-3176, 2009. e-Pub 2009. PMID: 19349551.
149. Tu, S, Lopez, A, Leibovici, D, Bilen, MA, Evliyaoglu, F, Aparicio, A, Guo, CC, Kuban, DA, Johnson, MM, Pisters, LL. Ductal adenocarcinoma of the prostate. Cancer 115(13):2872-2880, 2009. e-Pub 2009. PMID: 19402048.
150. Parker PA, Pettaway CA, Babaian RJ, Pisters LL, Miles B, Fortier A, Wei Q, Carr DD, Cohen L. The effects of a presurgical stress management intervention for men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 27(19):3169-76, 2009. e-Pub 2009.
151. Tu SM, Lopez A, Leibovici D, Bilen MA, Evliyaogli F, Aparicio A, Guo CC, Kuban DA, Johnson MM, Pisters LL. Ductal adenocarcinoma of the prostate: clinical features and implications after local therapy. Cancer 115(13):2872-80, 2009. e-Pub 2009.
152. Davis, JW, Chang, DW, Chevray, PM, Wang, R, Shen, Y, Wen, S, Pettaway, CA, Pisters, LL, Swanson, DA, Madsen, LT, Huber, N, Troncoso, P, Babaian, RJ, Wood, CG. Randomized Phase II Trial Evaluation of Erectile Function after Attempted Unilateral Cavernous Nerve-Sparing Retropubic Radical Prostatectomy With Versus Without Unilateral Sural Nerve Grafting for Clinically Localized Prostate Cancer. European urology 55(5):1135-1144, 2009. e-Pub 2009. PMID: 18783876.
153. Davis JW, Chang DW, Chevray P, Wang R, Shen Y, Wen S, Pettaway CA, Pisters LL, Swanson DA, Madsen LT, Huber N, Troncoso P, Babaian RJ, Wood CG. Randomized phase II trial evaluation of erectile function afer attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer. Eur Urol 55(5):1135-43, 2009. e-Pub 2009.
154. Gorbatiy V, Spiess PE, Pisters LL. The Growing Teratoma Syndrome: The Current Review of Literature. Indian Journal of Urology 25(2):186-189. e-Pub 2009.
155. Svatek, RS, Spiess, PE, Sundi, D, Tu, S, Tannir, NM, Brown, G, Kamat, A, Wood, CG, Pisters, LL. Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection. Cancer 115(6):1310-1317, 2009. e-Pub 2009. PMID: 19156903.
156. Forrest, JB, Clemens, JQ, Finamore, P, Leveille, R, Lippert, M, Pisters, LL, Touijer, K, Whitmore, K. AUA Best Practice Statement for the Prevention of Deep Vein Thrombosis in Patients Undergoing Urologic Surgery. Journal of Urology 181(3):1170-1177, 2009. e-Pub 2009. PMID: 19152926.
157. Tsavachidou, D, McDonnell, TJ, Wen, S, Wang, X, Vakar, F, Pisters, LL, Pettaway, CA, Wood, CG, Do, K, Thall, PF, Stephens, C, Efstathiou, E, Taylor, R, Menter, DG, Troncoso, P, Lippman, SM, Logothetis, CJ, Kim, J. Selenium and vitamin E. Journal of the National Cancer Institute 101(5):306-320, 2009. e-Pub 2009. PMID: 19244175.
158. Forrest JB, Clemens JQ, Finamore P, Leveillee R, Lippert M, Pisters LL, Touijer K, Whitmore K, Association AU. AUA best practice statement for the prevention of deep vein thrombosis in patients undergoing urologic surgery. J Urol 181(3):1170-7, 2009. e-Pub 2009.
159. Svatek RS, Spiess PE, Sundi D, Tu SM, Tannir NM, Brown GA, Kamat AM, Wood CG, Pisters LL. Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection. Cancer 115(6):1310-7, 2009. e-Pub 2009.
160. Tsavachidoiu D, McDonnell TJ, Wen S, Wang X, Vakar-Lopez F, Pisters LL, Pettaway CA, Wood CG, Do KA, Thall PF, Stephens C, Efstathiou E, Taylor R, Menter DG, Troncoso P, Lippman SM, Logothetis CJ, Kim J. Selenium and vitamin E: cell type-and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst 101(5):306-20, 2009. e-Pub 2009.
161. Williams IV, DH, Karpman, E, Sander, JC, Spiess, PE, Pisters, LL, Lipshultz, LI. Pretreatment Semen Parameters in Men With Cancer. Journal of Urology 181(2):736-740, 2009. e-Pub 2009. PMID: 19091343.
162. Williams DH, Karpman E, Sander JC, Spiess PE, Pisters LL, Lipshultz LI. Pretreatment semen parameters in men with cancer. J Urol 181(2):736040, 2009. e-Pub 2009.
163. Mathew, P, Pisters, LL, Wood, CG, Papadopoulos, JN, Williams, D, Thall, PF, Wen, S, Horne, E, Oborn, CJ, Langley, RR, Fidler, IJ, Pettaway, CA. Neoadjuvant Platelet Derived Growth Factor Receptor Inhibitor Therapy Combined With Docetaxel and Androgen Ablation for High Risk Localized Prostate Cancer. Journal of Urology 181(1):81-87, 2009. e-Pub 2009. PMID: 19012911.
164. Guo, CC, Pisters, LL, Troncoso, P. Prostate cancer invading the rectum. Pathology 41(6):539-543, 2009. e-Pub 2009. PMID: 19900102.
165. Kassouf, W, Agarwal, PK, Barton Grossman, H, Leibovici, D, Munsell, M, Siefker-Radtke, AO, Pisters, LL, Swanson, DA, Dinney, CP, Kamat, A. Outcome of Patients With Bladder Cancer With pN+ Disease After Preoperative Chemotherapy and Radical Cystectomy. Urology 73(1):147-152, 2009. e-Pub 2009. PMID: 18848348.
166. Kassouf W, Agarwal PK, Grossman HB, Leibovici D, Munsell MF, Siefker-Radther A, Pisters LL, Swanson DA, Dinney CP, Kamat AM. Outcome of patients with Bladder Cancer with pN+ Disease After Preoperative Chemotherapy and Radical Cystectomy. J Urol 73(1):147-52, 2009. e-Pub 2009.
167. Mathew P, Pisters LL, Wood CG, Papadopoulos JN, Williams DL, Thall PF, Wen S, Horne E, Oborn CJ, Langley R, Fidler IJ, Pettaway CA. Neoadjuvant platelet derived growth factor receptor inhibitor therapy combined with docetaxel and androgen ablation for high risk localized prostate cancer. J Urol 181(1):81-7, 2009. e-Pub 2009.
168. Spiess, PE, Pisters, LL, Liu, P, Pettaway, CA, Kamat, A, Gomez, JA, Tannir, NM. Malignant transformation of testicular teratoma. Urologic Oncology: Seminars and Original Investigations 26(6):595-599, 2008. e-Pub 2008. PMID: 18367105.
169. Ward, JF, Pagliaro, LC, Pisters, LL. Salvage Therapy for Radiorecurrent Prostate Cancer. Current Problems in Cancer 32(6):242-271, 2008. e-Pub 2008. PMID: 19064119.
170. Babaian RJ, Donnelly B, Bahn D, Baust JG, Dineen M, Ellis D, Katz A, Pisters LL, Rukstalis D, Shinokara K, Thrasher JB. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol 180(5):1993-2004, 2008. e-Pub 2008.
171. Spiess PE, Pisters LL, Liu P, Pettaway CA, Kamat AM, Gomez JA, Tannir NM. Malignant transformation of testicular teratoma: a chemoresistant phenotype. Urol Oncol 26(6):595-9, 2008. e-Pub 2008.
172. Ward JF, Pagliaro LC, Pisters LL. Salvage Therapy for radiorecurrent prostate cancer. Curr Probl Cancer 32(6):242-71, 2008. e-Pub 2008.
173. Jones, JS, Rewcastle, JC, Donnelly, JB, Lugnani, FM, Katz, AE. Whole Gland Primary Prostate Cryoablation. Journal of Urology 180(2):554-558, 2008. e-Pub 2008. PMID: 18550117.
174. Pisters, LL, Rewcastle, JC, Donnelly, JB, Lugnani, FM, Katz, AE, Jones, JS. Salvage Prostate Cryoablation. Journal of Urology 180(2):559-564, 2008. e-Pub 2008. PMID: 18554664.
175. Jones JS, Rewcastle JC, Donnelly BJ, Lugnani FM, Pisters LL, Katz AE. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry. J Urol 180(2):554-8, 2008. e-Pub 2008.
176. Pisters LL, Rewcastle JC, Donnelly BJ, Lugnani FM, Katz AE, Jones JS. Salvage prostate cryoablation initial results from the cryo on-line data registry. J Urol 180(2):559-63, 2008. e-Pub 2008.
177. Sanda, MG, Dunn, RL, Michalski, J, Sandler, H, Northouse, L, Hembroff, L, Lin, X, Greenfield, TK, Litwin, M, Saigal, C, Mahadevan, A, Klein, EA, Kibel, AS, Pisters, LL, Kuban, DA, Kaplan, I, Wood, DP, Ciezki, J, Shah, N, Wei, JT. Quality of life and satisfaction with outcome among prostate-cancer survivors. New England Journal of Medicine 358(12):1250-1261, 2008. e-Pub 2008. PMID: 18354103.
178. Sanda MG, Rodney RL, Dunn MS, Michalski J, Sandler HM, Northhouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Kibel A, Pisters LL, Kuban DA, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT. Quality of Life and Satisfaction with Outcome Among Prostate Cancer Survivors and their Spouses. N Engl J Med 358(12):1250-61, 2008. e-Pub 2008.
179. Spiess, PE, Busby, JE, Jordan, JJ, Steinberg, JR, Bassett Jr, R, Davuluri, R, Burt, K, Troncoso, P, Lee, AK, Taylor, SH, Pisters, LL. Can digital rectal examination or transrectal ultrasonography biopsy findings predict the side of nodal metastasis in prostate cancer?. Urologic Oncology: Seminars and Original Investigations 26(1):25-30, 2008. e-Pub 2008. PMID: 18190826.
180. Kassouf, W, Agarwal, PK, Herr, HW, Munsell, M, Spiess, PE, Brown, G, Pisters, LL, Barton Grossman, H, Dinney, CP, Kamat, A. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer. Journal of Clinical Oncology 26(1):121-126, 2008. e-Pub 2008. PMID: 18165646.
181. Sabichi, AL, Lerner, SP, Atkinson, N, Barton Grossman, H, Caraway, NP, Dinney, CP, Penson, DF, Matin, S, Kamat, A, Pisters, LL, Lin, DW, Katz, RL, Brenner, DE, Hemstreet, GP, Wargo, M, Bleyer, WA, Sanders, WH, Clifford, JL, Parnes, HL, Lippman, SM. Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clinical Cancer Research 14(1):224-229, 2008. e-Pub 2008. PMID: 18172274.
182. Leibovici D, Spiess PE, Heller L Rodgriguez-Bigas M, Chang G, LL01/2008 P. Salvage Surgery for Locally Recurrent Prostate Cancer After Radiation Therapy: Tricks of the Trade". Urologic Oncology 26(1):9-16, 2008. e-Pub 2008.
183. Spiess PE, Busby JE, Jordan JJ, Steinberg JR, Bassett RL, Davuluri R, Burt K, Troncoso P, Lee AK, Taylor SH, Pisters LL. Can Digital Rectal Examination or Transrectal Ultrasonography biopsy findings predict the side of nodal metastasis in prostate cancer?. Urologic Oncology 26(1):25-30, 2008. e-Pub 2008.
184. Sabichi AL, Lerner SP, Atkinson EN, Grossman HB, Caraway NP, Dinney CP, Penson DF, Matin S, Kamat A, Pisters LL, Lin DW, Katz RL, Brenner DE, Hemstreet GP III, Wargo M, Bleyer A, Sanders WH, Clifford JL, Parnes HL, Lippman SM. Phase III Prevention Trial of Fenretinide in Patients with Resected Non-Muscle-Invasive Bladder Cancer. Clinical Cancer Research 14(1):224-229, 2008. e-Pub 2008.
185. Kassouf W, Agarwal P, Herr HW, Munsell MF, Spiess PE, Brown GA, Pisters LL, Grossman HB, Dinney CP, Kamat AM. Lymph Node Density Is Superior to TNM Nodal Status in Predicting Disease-Specific Survival After Radical Cystectomy for Bladder Cancer: Analysis of Pooled Data from MDACC and MSKCC. Journal of Clinical Oncology 26:121-126, 2008. e-Pub 2008.
186. Spiess, PE, Tannir, NM, Tu, S, Brown, G, Liu, P, Kamat, A, Wood, CG, Evans, JG, Pisters, LL. Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection. Cancer 110(12):2700-2708, 2007. e-Pub 2007. PMID: 17948916.
187. Spiess, PE, Tannir, NM, Brown, G, Liu, P, Tu, S, Evans, JG, Pisters, LL. Recurrence in Nonseminomatous Germ Cell Testis Tumor Patients with No Viable Tumor at Postchemotherapy Retroperitoneal Lymph Node Dissection. Urology 70(6):1173-1178, 2007. e-Pub 2007. PMID: 18158041.
188. Shetty, A, Stafford, J, Elliott, A, Kassouf, W, Brown, G, Stephens, C, Tinkey, PT, Bidaut, L, Pisters, LL, Hazle, JD. Magnetic resonance imaging assessment of a convective therapy delivery paradigm in a canine prostate model. Journal of Magnetic Resonance Imaging 26(6):1672-1677, 2007. e-Pub 2007. PMID: 17968888.
189. Spiess PE, Tannir NM, Tu SM, Brown GA, Liu P, Kamat AM, Wood CG, Evans JG, Pisters LL. Viable Germ Cell Tumor at Post-Chemotherapy RPLND: Can We Predict Who’s at Risk of Progression?. Cancer 110(12):2700-2708, 2007. e-Pub 2007.
190. Spiess PE, Tannir NM, Brown GA, Liu P, Tu SM, Evans JG, Pisters LL. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection. Urol 70(6):1173-8, 2007. e-Pub 2007.
191. Shetty AM, Stafford RJ, Elliott AM, Kassouf W, Brown GA, Stephens LC, Tinkey PT, Bidaut L, Pisters LL, Hazle JD. Magnetic resonance imaging assessment of a convective therapy delivery paradigm in a canine prostate model. J Magn Reson Imaging 26(6):1672-7, 2007. e-Pub 2007.
192. Pisters LL. Treatment failure after primary and salvage therapy for prostate cancer. Cancer 112(2):225-227, 2007. e-Pub 2007.
193. Kassouf, W, Brown, G, Shetty, A, Hazle, JD, Stafford, J, Rosser, CJ, Stephens, C, Tinkey, PT, Pisters, LL. An In Vivo Orthotopic Canine Model to Evaluate Distribution of Intraprostatic Injectate. Urology 70(4):822-825, 2007. e-Pub 2007. PMID: 17991580.
194. Kassouf W, Brown GA, Shetty A, Hazle JD, Stafford RJ, Rosser CJ, Stephens C, Tinkey PT, Pisters LL. An in vivo orthotopic canine model to evaluate distribution of intraprostatic injectate: implications for gene therapy and drug delivery for prostate cancer. Urology 70(4):822-5, 2007. e-Pub 2007.
195. Leibovici, D, Kassouf, W, Pisters, LL, Pettaway, CA, Wu, X, Dinney, CP, Barton Grossman, H. Organ Preservation for Muscle-Invasive Bladder Cancer by Transurethral Resection. Urology 70(3):473-476, 2007. e-Pub 2007. PMID: 17905099.
196. Lebovici D, Kassouf W, Pisters LL, Pettaway CA, Wu X, Dinney CP, Grossman HB. Organ preservation for muscle-invasive bladder cancer by transurethral resection. Urology 70(3):473-6, 2007. e-Pub 2007.
197. Black, P, Basen-Engquist, KM, Wang, X, Swartz, RJ, Eddings, T, Matin, S, Swanson, DA, Wood, CG, Pisters, LL, Babaian, RJ, Troncoso, P, Pettaway, CA. A randomized prospective trial evaluating testosterone, haemoglobin kinetics and quality of life, during and after 12 months of androgen deprivation after prostatectomy. BJU international 100(1):63-69, 2007. e-Pub 2007. PMID: 17552954.
198. Kamat, A, Dinney, CP, Gee, JR, Barton Grossman, H, Siefker-Radtke, AO, Tamboli, P, Detry, MA, Robinson, TL, Pisters, LL. Micropapillary bladder cancer. Cancer 110(1):62-67, 2007. e-Pub 2007. PMID: 17542024.
199. Kamat AM, Dinney CPN, Gee JR, Millikan JE, Grossman HB, Siefker-Radtke AO, Tamboli P, Detry MA, Robinson TL, Pisters LL. Micropapillary bladder cancer: A review of the M. D. Anderson Cancer Center experience with 100 consecutive patients. Cancer 110(1):62-7, 2007. e-Pub 2007.
200. Black PC, Basin-Engquistk, Wang X, Swartz RJ, Eddings T, Matin SF, Swanson D, Wood CG, Pisters LL, Babaian RJ, Troncosco P, Pettaway CA. A Randomized Prospective Trial Evaluation Testerone Hemoglobin Kinetics and quality of life, during and after 12 months of Androgen Deprivation after Prostatectomy results from the Postoperative Adjuvant Androgen. BJU Int 100(1):63-9, 2007. e-Pub 2007.
201. De, EJ, Pisters, LL, Pettaway, CA, Scott, SM, Westney, OL. Salvage Prostatectomy With Bladder Neck Closure, Continent Catheterizable Stoma and Bladder Augmentation. Journal of Urology 177(6):2200-2204, 2007. e-Pub 2007. PMID: 17509319.
202. Frank, SJ, Pisters, LL, Davis, JW, Lee, AK, Bassett Jr, R, Kuban, DA. An Assessment of Quality of Life Following Radical Prostatectomy, High Dose External Beam Radiation Therapy and Brachytherapy Iodine Implantation as Monotherapies for Localized Prostate Cancer. Journal of Urology 177(6):2151-2156, 2007. e-Pub 2007. PMID: 17509305.
203. Shinn, EH, Basen-Engquist, KM, Thornton, B, Spiess, PE, Pisters, LL. Health Behaviors and Depressive Symptoms in Testicular Cancer Survivors. Urology 69(4):748-753, 2007. e-Pub 2007. PMID: 17445663.
204. Spiess, PE, Kassouf, W, Brown, G, Kamat, A, Liu, P, Gomez, JA, Tu, S, Tannir, NM, Pisters, LL. Surgical Management of Growing Teratoma Syndrome. Journal of Urology 177(4):1330-1334, 2007. e-Pub 2007. PMID: 17382725.
205. Shinn EH, Basen-Engquist K, Thornton B, Spiess PE, Pisters LL. Health behaviors and depressive symptoms in testicular cancer survivors. Urol 69(4):748-753, 2007. e-Pub 2007.
206. Efstathiou, E, Troncoso, P, Wen, S, Do, K, Pettaway, CA, Pisters, LL, McDonnell, TJ, Logothetis, CJ. Initial modulation of the tumor microenvironment accounts for thalidomide activity in prostate cancer. Clinical Cancer Research 13(4):1224-1231, 2007. e-Pub 2007. PMID: 17317833.
207. Spiess PE, Lee AK, Busby JE, Jordan JJ, Hernandez M, Burt K, Troncoso P, Merriman KW, Pisters LL. Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome?. BJU Int 99(2):321-5, 2007. e-Pub 2007. PMID: 17155975.
208. Spiess, PE, Brown, G, Liu, P, Tu, S, Tannir, NM, Evans, JG, Kamat, A, Kassouf, W, Pisters, LL. Recurrence Pattern and Proposed Surveillance Protocol Following Post-Chemotherapy Retroperitoneal Lymph Node Dissection. Journal of Urology 177(1):131-138, 2007. e-Pub 2007. PMID: 17162023.
209. Spiess PE, Brown GA, Liu P, Tu SM, Tannir NM, Evans JG, Kamat AM, Kassouf W, Pisters LL. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection. J Urol 177(1):131-138, 2007. e-Pub 2007.
210. Efstathiou E, Troncoso P, Wen S, Do KA, Pettaway CA, Pisters LL, McDonnell TJ, Logothetis CJ. Initial modulation of the tumor microenvironment accounts for thalidomide activity in prostate cancer. Clin Cancer Res 13(4):1224-1231, 2007. e-Pub 2007.
211. Pisters LL, Brown G, Spiess PE. Inside the Genetic Heterogeneity of Renal Cell Carcinoma: Will the c-Met Proto-Oncogene Be the Next Therapeutic Target?. Kidney Cancer Journal 5(1):23-27, 2007. e-Pub 2007.
212. Pendleton J, Pisters LL, Nakamura K, Anai S, Rosser CJ. Neoadjuvant Therapy Before Radical Prostatectomy: Where Have We Been? Where Are We Going?. Urol Oncol 25(1):11-18, 2007. e-Pub 2007.
213. De E, Pisters LL, Pettaway CA, Scott S, Westney OL. Salvage prostatectomy with bladder neck closure, continent catheterizable stoma and bladder augmentation: Feasibility and patient reported continence outcomes at 32 months. J Urol 177(6):2200-2204, 2007. e-Pub 2007.
214. Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol 177(6):2151-2156, 2007. e-Pub 2007.
215. Spiess PE, Kassouf W, Brown GA, Kamat AM, Liu P, Gomez JA, Tu SM, Tannir NM, Pisters LL. Surgical management of growing teratoma syndrome: the M. D. Anderson Cancer Center experience. J Urol 177(4):1330-1334, 2007. e-Pub 2007.
216. Brown GA, Busby JE, Wood CG, Pisters LL, Dinney CP, Swanson DA, Grossman HB, Pettaway CA, Munsell MF, Kamat AM, Matin SF. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?. BJU Int 98(6):1176-1180, 2006. e-Pub 2006. PMID: 17125474.
217. Evans JG, Spiess PE, Kamat AM, Wood CG, Hernandez M, Pettaway CA, Dinney CP, Pisters LL. Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience. J Urol 176(4(Pt1)):1463-1467, 2006. e-Pub 2006. PMID: 16952661.
218. Spiess PE, Brown GA, Liu P, Tannir NM, Tu SM, Evans JG, Czerniak B, Kamat AM, Pisters LL. Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer. Cancer 107(7):1483-1490, 2006. e-Pub 2006. PMID: 16944541.
219. Spiess PE, Brown GA, Pisters LL, Liu P, Tu SM, Evans JG, Kamat AM, Black P, Tannir NM. Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?. Cancer 107(7):1503-1510, 2006. e-Pub 2006. PMID: 16944534.
220. Izawa JI, Busby JE, Morganstern N, Vakar-Lopez F, Scott SM, Pisters LL. Histological changes in prostate biopsies after salvage cryotherapy: effect of chronology and the method of biopsy. BJU Int 98(3):554-558, 2006. e-Pub 2006. PMID: 16925753.
221. Westney OL, Scott S, Wood C, Eddings T, Johnson MM, Taylor JM, McGuire E, Pisters LL. Suburethral sling at the time of radical prostatectomy in patients at high risk of postoperative incontinence. BJU Int 98(2):308-313, 2006. e-Pub 2006. PMID: 16879670.
222. Strom SS, Kamat AM, Gruschkus SK, Gu Y, Wen S, Cheung MR, Pisters LL, Lee AK, Rosser CJ, Kuban DA. Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer 107(3):631-639, 2006. e-Pub 2006. PMID: 16802288.
223. Rosser CJ, Kamat AM, Pendleton J, Robinson TL, Pisters LL, Swanson DA, Babaian RJ. Impact of fellowship training on pathologic outcomes and complication rates of radical prostatectomy. Cancer 107(1):54-59, 2006. e-Pub 2006. PMID: 16708356.
224. Spiess PE, Lee AK, Leibovici D, Wang X, Do KA, Pisters LL. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy. Cancer 107(2):275-280, 2006. e-Pub 2006. PMID: 16770783.
225. Rosser CJ, Kamat AM, Wang X, Do KA, Naya Y, Hoover DC, Troncoso P, Sanches-Ortiz RF, Pisters LL. Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with radical prostatectomy. Urology 67(4):769-773, 2006. e-Pub 2006. PMID: 16584762.
226. Sabichi AL, Lee JJ, Taylor RJ, Thompson IM, Miles BJ, Tangen CM, Minasian LM, Pisters LL, Caton JR, Basler JW, Lerner SP, Menter DG, Marshall JR, Crawford ED, Lippman SM. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study. Clin Cancer Res 12(7(Pt1)):2178-2184, 2006. e-Pub 2006. PMID: 16609032.
227. Taylor, SH, Merriman, K, Spiess, PE, Pisters, LL. Inadequacies of the current American Joint Committee on Cancer staging sytem for prostate cancer. Cancer 106(3):559-565, 2006. e-Pub 2006. PMID: 16369982.
228. Taylor SH, Merriman KW, Spiess PE, Pisters L. Inadequacies of the current American Joint Committee on cancer staging system for prostate cancer. Cancer 106(3):559-65, 2006. e-Pub 2006.
229. Kamat AM, Gee JR, Dinney CP, Grossman HB, Swanson DA, Millikan RE, Detry MA, Robinson TL, Pisters LL. The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma. J Urol 175(5):1967, 2006. e-Pub 2006. PMID: 16469571.
230. Leibovici D, Spiess PE, Agarwal PK, Tu SM, Pettaway CA, Hitzhusen K, Millikan RE, Pisters LL. Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level. Cancer 109(2):198-204, 2006. e-Pub 2006.
231. Leibovici D, Kamat AM, Pettaway CA, Pagliaro L, Rosser CJ, Logothetis C, Pisters LL. Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancer. J Urol 174(6):2186-2190, 2005. e-Pub 2005. PMID: 16280761.
232. Cheung, MR, Kamat, A, de Crevoisier, R, Allen, P, Lee, AK, Tucker, SL, Pisters, LL, Babaian, RJ, Kuban, DA. Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy. International Journal of Radiation Oncology Biology Physics 63(1):134-140, 2005. e-Pub 2005. PMID: 16111581.
233. Rosser CJ, Kamat AM, Wang X, Do KA, Sanchez-Ortiz RF, Kuban DA, Lee AK, Cheung R, Chichakli R, Pisters LL. Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer?. Urology 66(2):327-631, 2005. e-Pub 2005. PMID: 16040084.
234. Kim J, Sun P, Lam YW, Troncoso P, Sabichi AL, Babaian RJ, Pisters LL, Pettaway CA, Wood CG, Lippman SM, McDonnell TJ, Lieberman R, Logothetis C, Ho SM. Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer. Cancer Epidemiol Biomarkers Prev 14(7):1697-1702, 2005. e-Pub 2005. PMID: 16030104.
235. Ahrar K, Matin S, Wood CG, Wallace MJ, Gupta S, Madoff DC, Rao S, Tannir NM, Jonasch E, Pisters LL, Rozner MA, Kennamer DL, Hicks ME. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J Vasc Interv Radiol 16(5):679-688, 2005. e-Pub 2005. PMID: 15872323.
236. Leibovici D, Lee AK, Cheung RM, Spiess PE, Kuban DA, Rosser CJ, Shen Y, Yang Y, Chichakli R, Pisters LL. Symptomatic local recurrence of prostate carcinoma after radiation therapy. Cancer 103(10):2060-2066, 2005. e-Pub 2005. PMID: 15822114.
237. Cheung, MR, Tucker, SL, Lee, AK, de Crevoisier, R, Dong, L, Kamat, A, Pisters, LL, Kuban, DA. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy. International Journal of Radiation Oncology Biology Physics 61(4):993-1002, 2005. e-Pub 2005. PMID: 15752878.
238. Leibovici D, Pagliaro L, Rosser CJ, Pisters LL. Salvage surgery for bulky local recurrence of prostate cancer following radical prostatectomy. J Urol 173(3):781-783, 2005. e-Pub 2005. PMID: 15711269.
239. Kamat AM, Carpenter SM, Czerniak BA, Pisters LL. Metastatic penile cancer in a young Caucasian male: impact of delayed diagnosis. Urol Oncol 23(2):130-131, 2005. e-Pub 2005. PMID: 15869998.
240. Cheung, MR, Tucker, SL, Lee, AK, Dong, L, Kamat, A, Pisters, LL, Kuban, DA. Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy. International Journal of Radiation Oncology Biology Physics 61(1):14-19, 2005. e-Pub 2005. PMID: 15629589.
241. 86Cheung R, Kamat AM, de Crevoisier R, Allen PK, Lee AK, Tucker SL, Pisters LL, Babaian RJ, Kuban D. Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy. Int J Radiat Oncol Biol Phys 63(1):134-140, 2005. e-Pub 2005.
242. Cheung R, Tucker SL, Lee AL, Dong L, Kamat A, Pisters LL, Kuban DA. Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 61(1):14-19, 2005. e-Pub 2005.
243. Cheung R, Tucker SL, Lee AK, de Crevoisier R, Dong L, Kamat A, Pisters LL, Kuban D. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 61(4):993-1002, 2005. e-Pub 2005.
244. Leibovici D, Kamat AM, Do KA, Pettaway CA, Ng CS, Evans RB, Rodriguez-Bigas M, Skibber J, Wang X, Pisters LL. Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancer. Prostate 62:101-104, 2005. e-Pub 2005. PMID: 15389800.
245. Siefker-Radtke AO, Dinney CP, Abrahams NA, Moran C, Shen Y, Pisters LL, Grossman HB, Swanson DA, Millikan RE. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. J Urol 172:481-484, 2004. e-Pub 2004. PMID: 15247709.
246. Rosser CJ, Kuban DA, Lee SJ, Levy LB, Pettaway C, Kamat AM, Chichakli R, Lee A, Cheung RM, Sanchez-Ortiz R, Pisters LL. Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer. J Natl Med Assoc 96:939-944, 2004. e-Pub 2004. PMID: 15253325.
247. Kamat AM, Rosser CJ, Levy LB, Chichakli R, Lee AK, Cheung MR, Pisters LL. Rise in serum PSA of 1.5 ng/mL above 24-month nadir after external beam radiotherapy is predictive of biochemical failure. Urology 63:1132-1137, 2004. e-Pub 2004. PMID: 15183966.
248. Rosser CJ, Tanaka M, Pisters LL, Tanaka N, Levy LB, Hoover DC, Grossman HB, McDonnell TJ, Kuban DA, Meyn RE. Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation. Cancer Gene Ther 11:273-279, 2004. e-Pub 2004. PMID: 14765130.
249. Pisters LL, Pettaway CA, Troncoso P, McDonnell TJ, Stephens LC, Wood CG, Do KA, Brisbay SM, Wang X, Hossan EA, Evans RB, Soto C, Jacobson MG, Parker K, Merritt JA, Steiner MS, Logothetis CJ. Evidence that transfer of functional p53 protein results in increased apoptosis in prostate cancer. Clin Cancer Res 10:2587-2593, 2004. e-Pub 2004. PMID: 15102659.
250. Rosser CJ, Tanaka N, Stafford RJ, Price RE, Hazle JD, Tanaka M, Kamat AM, Pisters LL. Feasibility to delineate distribution of solution injected intraprostatic using an ex-vivo canine model. Gene Ther Mol Biol 8:509-514, 2004. e-Pub 2004.
251. Siefker-Radtke AO, Walsh GL, Pisters LL, Shen Y, Swanson DA, Logothetis CJ, Millikan RE. Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience. J Urol 171:145-148, 2004. e-Pub 2004. PMID: 14665863.
252. Kamat AM, Huang SF, Bermejo CE, Rosser CJ, Pettaway CA, Pisters PW, Guitreau DP, Pisters LL. Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer. J Urol 170:1868-1871, 2003. e-Pub 2003. PMID: 14532795.
253. Rosser CJ, Kuban DA, Levy LB, Pettaway CA, Chichakli R, Kamat AM, Sanchez-Ortiz RF, Pisters LL. Clinical features and treatment outcome of Hispanic men with prostate cancer following external beam radiotherapy. J Urol 170:1856-1859, 2003. e-Pub 2003. PMID: 14532792.
254. Sweeney P, Wood CG, Pisters LL, Slaton JW, Vaporciyan A, Munsell M, Carpenter S, Putnam J, Swisher SG, Walsh G, Swanson D, Dinney CP. Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi. Urol Oncol 21:327-333, 2003. e-Pub 2003. PMID: 14670538.
255. Taylor N, Kelly JF, Kuban DA, Babaian RJ, Pisters LL, Pollack A. Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 56:755-763, 2003. e-Pub 2003. PMID: 12788182.
256. Sweeney P, Millikan R, Donat M, Wood CG, Radtke AS, Pettaway CA, Grossman HB, Dinney CP, Swanson DA, Pisters LL. Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?. J Urol 169:2113-2117, 2003. e-Pub 2003. PMID: 12771730.
257. Rosser CJ, Levy LB, Kuban DA, Chichakli R, Pollack A, Lee A, Pisters LL. Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostate. J Urol 169:2160-2165, 2003. e-Pub 2003. PMID: 12771739.
258. Izawa JI, Morganstern N, Chan DM, Levy LB, Scott SM, Pisters LL. Incomplete glandular ablation after salvage cryotherapy for recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 56:468-472, 2003. e-Pub 2003. PMID: 12738322.
259. Rosser CJ, Reyes AO, Vakar-Lopez F, Levy LB, Kuban DA, Hoover DC, Lee AK, Pisters LL. Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma. Int J Radiat Oncol Biol Phys 56:1-6, 2003. e-Pub 2003. PMID: 12694817.
260. Siefker-Radtke AO, Gee J, Shen Y, Wen S, Daliani D, Millikan RE, Pisters LL. Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience. J Urol 169:1295-1298, 2003. e-Pub 2003. PMID: 12629346.
261. Sexton WJ, Wood CG, Kim R, Pisters LL. Repeat retroperitoneal lymph node dissection for metastatic testis cancer. J Urol 169:1353-1356, 2003. e-Pub 2003. PMID: 12629359.
262. Rosser CJ, Kuban DA, Levy LB, Chichakli R, Pollack A, Lee AK, Pisters LL. Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer. J Urol 168:2001-2005, 2002. e-Pub 2002. PMID: 12394695.
263. Sweeney P, El-Naggar AK, Lin SH, Pisters LL. Biological significance of c-met over expression in papillary renal cell carcinoma. J Urol 168:51-55, 2002. e-Pub 2002. PMID: 12050491.
264. Izawa JI, Madsen LT, Scott SM, Tran JP, McGuire EJ, Von Eschenbach AC, Pisters LL. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol 20:2664-2671, 2002. e-Pub 2002. PMID: 12039928.
265. Tu SM, Reyes A, Maa A, Bhowmick D, Pisters LL, Pettaway CA, Lin SH, Troncoso P, Logothetis CJ. Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features. Cancer 94:2610-2617, 2002. e-Pub 2002. PMID: 12173328.
266. Davis JW, Pisters LL, Doviak MJ, Donat SM. Early nasogastric tube removal combined with metoclopramide after postchemotherapy retroperitoneal lymph node dissection for metastatic testicular nonseminomatous germ cell tumor. Urology 59:579-583, 2002. e-Pub 2002. PMID: 11927318.
267. Fizazi K, Martinez LA, Sikes CR, Johnston DA, Stephens LC, McDonnell TJ, Logothetis CJ, Trapman J, Pisters LL, Ordonez NG, Troncoso P, Navone NM. The association of p21((WAF-1/CIP1)) with progression to androgen-independent prostate cancer. Clin Cancer Res 8:775-781, 2002. e-Pub 2002. PMID: 11895908.
268. Rosser, CJ, Chichakli, R, Levy, LB, Kuban, DA, Smith, LG, Pisters, LL. Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation. Journal of Urology 168(2):536-541, 2002. e-Pub 2002. PMID: 12131304.
269. Scott SM, Evans RB, Pisters LL. Prostate cancer rates decline. Physician Assistant 26:28-43, 2002. e-Pub 2002.
270. Mian BM, Bhadkamkar N, Slaton JW, Pisters PW, Daliani D, Swanson DA, Pisters LL. Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol 167:65-70, 2002. e-Pub 2002. PMID: 11743277.
271. *Rosser CJ, Chichakli R, Levy LB, Kuban DA, Smith LG, Pisters LL. Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation. J Urol 168:536-541, 2002. e-Pub 2002.
272. Kent D, Gee JR, Amato RJ, Pisters LL. Successful management of metastatic urethral cancer with organ preservation. J Urol 166:2308, 2001. e-Pub 2001. PMID: 11696764.
273. Giesler EJ, Gee JR, Reece GP, Pettaway CA, Pollock RE, Pisters LL. Cutaneous metastases of penile squamous cell carcinoma following en bloc resection of inguinal recurrence with immediate pedicle flap reconstruction. J Urol 166:1384-1385, 2001. e-Pub 2001. PMID: 11547082.
274. Sexton WJ, Lance RE, Reyes AO, Pisters PW, Tu SM, Pisters LL. Adult prostate sarcoma: the M. D. Anderson Cancer Center Experience. J Urol 166:521-525, 2001. e-Pub 2001. PMID: 11458058.
275. Lance RS, Dinney CP, Swanson D, Babaian RJ, Pisters LL, Palmer LJ, Grossman HB. Radical cystectomy for invasive bladder cancer in the octogenarian. Oncol Rep 8:723-726, 2001. e-Pub 2001. PMID: 11410772.
276. Pisters LL, Wang XH, Chung LW, Hsieh JT. Differential expression of c-erb B2/neu, epidermal growth factor receptor, cytokeratin 8, and the prostatic steroid-binding protein gene in rat ventral prostate during postnatal development. Prostate 47:164-171, 2001. e-Pub 2001. PMID: 11351345.
277. Pisters, LL, Westney, OL, Scott, SM, Swanson, DA, Wood, CG, Von Eschenbach, A, Dinney, CP, McGuire, EJ. Pubourethral sling simultaneous with radical retropubic prostatectomy for patients at high risk for postprostatectomy incontinence. Prostate Cancer and Prostatic Diseases 3:S34, 2000. e-Pub 2000. PMID: 12497142.
278. Izawa JI, Ajam K, McGuire E, Scott S, von Eschenbach AC, Skibber J, Pisters LL. Major surgery to manage definitively severe complications of salvage cryotherapy for prostate cancer. J Urol 164:1978-1981, 2000. e-Pub 2000. PMID: 11061895.
279. Pisters LL, Westney OL, Scott SM, Swanson DA, Wood CG, Von Eschenbach AC, Dinney CP, McGuire EJ. Puburethral sling simultaneous with radical retropubic prostatectomy for patients at high risk for postprostatectomy incontinence. Prostate Cancer Prostatic Dis 3(S1):S34, 2000. e-Pub 2000.
280. Pisters LL, English SF, Scott SM, Westney OL, Dinney CP, McGuire EJ. Salvage prostatectomy with continent catheterizable urinary reconstruction: a novel approach to recurrent prostate cancer after radiation therapy. J Urol 163:1771-1174, 2000. e-Pub 2000. PMID: 10799179.
281. Pettaway CA, Pisters LL, Troncoso P, Slaton J, Finn L, Kamoi K, Logothetis CJ. Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results. J Clin Oncol 18(5):1050-1057, 2000. e-Pub 2000. PMID: 10694556.
282. Corral DA, Varma DG, Jackson EF, Amato RJ, Donat SM, Pisters LL. Magnetic resonance imaging and magnetic resonance angiography before postchemotherapy retroperitoneal lymph node dissection. Urology 55:262-266, 2000. e-Pub 2000. PMID: 10688091.
283. Pisters, LL, Kuo, W. Current status of prostate-specific antigen testing in the united states. Journal of Pelvic Surgery 6(5):273-283, 2000. e-Pub 2000.
284. Pisters LL Kuo W. Current status of prostate-specific antigen testing in the United States. Journal of Pelvic Surgery 6(5):273-283, 2000. e-Pub 2000.
285. Corral DA, Cleary KR, Pisters LL. Renal cell carcinoma drop metastasis to the left spermatic vein in a patient with prior varicocele ligation. Journal of Pelvic Surgery 6:42-43, 2000. e-Pub 2000.
286. Donat SM, Slaton JW, Pisters LL, Swanson DA. Early nasogastric tube removal combined with metoclopramide after radical cystectomy and urinary diversion. J Urol 162:1599-1602, 1999. e-Pub 1999. PMID: 10524876.
287. Perrotte P, Tran J, McGuire EJ, Pisters LL. Effect of prior therapy on survival after salvage cryotherapy for recurrent prostate cancer. Prostate Cancer Prostatic Dis 2(S3):S25, 1999. e-Pub 1999.
288. Pisters LL, Pettaway CA, Hossan E, Evans RE, Steiner MS, Wood CG, Troncoso P, McDonnell TJ, Fenstenmacher MJ, Logothetis CJ. Intraprostatic AD-p53 gene therapy followed by radical prostatectomy: feasibility and preliminary results. Prostate Cancer Prostatic Dis 2(S3):S27, 1999. e-Pub 1999.
289. Pisters LL, Perrotte P, Scott SM, Greene GF, von Eschenbach AC. Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy. J Clin Oncol 17(8):2514-2520, 1999. e-Pub 1999. PMID: 10561317.
290. Perrotte P, Litwin MS, McGuire EJ, Scott SM, von Eschenbach AC, Pisters LL. Quality of life after salvage cryotherapy: the impact of treatment parameters. J Urol 162:398-402, 1999. e-Pub 1999. PMID: 10411046.
291. Levy DA, Cromeens DM, Evans R, Stephens LC, von Eschenbach AC, Pisters LL. Transrectal ultrasound-guided intraprostatic injection of absolute ethanol with and without carmustine: a feasibility study in the canine model. Urology 53(6):1245-1251, 1999. e-Pub 1999. PMID: 10367863.
292. Pisters LL, Dinney CP, Pettaway CA, Scott SM, Babaian RJ, von Eschenbach AC, Troncoso P. A feasibility study of cryotherapy followed by radical prostatectomy for locally advanced prostate cancer. J Urol 161:509-514, 1999. e-Pub 1999. PMID: 9915437.
293. Navone NM, Labate ME, Troncoso P, Pisters LL, Conti CJ, von Eschenbach AC, Logothetis CJ. p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential. J Urol 161:304-308, 1999. e-Pub 1999. PMID: 10037428.
294. Nowroozi MR, Pisters LL. The Current Status of Gene Therapy for Prostate Cancer. Cancer Control 5(6):522-531, 1998. e-Pub 1998. PMID: 10761101.
295. Greene GF, Pisters LL, Scott SM, Von Eschenbach AC. Predictive value of prostate specific antigen nadir after salvage cryotherapy. J Urol 160:86-90, 1998. e-Pub 1998. PMID: 9628611.
296. Pisters LL, Troncoso P, Navone N. Prolonged survival with metastatic prostate cancer to bone. J Urol 159:210, 1998. e-Pub 1998. PMID: 9598540.
297. English SF, Pisters LL, McGuire EJ. The use of the appendix as a continent catheterizable stoma. J Urol 159:747-749, 1998. e-Pub 1998. PMID: 9474139.
298. Westney OL, Pisters LL, Pettaway CA, Tu SM, Pollack A, Dinney CP. Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder. J Urol 159:792-795, 1998. e-Pub 1998. PMID: 9474150.
299. Pisters LL, el-Naggar AK, Luo W, Malpica A, Lin SH. C-met proto-oncogene expression in benign and malignant human renal tissues. J Urol 158:724-728, 1997. e-Pub 1997. PMID: 9258068.
300. Nesbitt JC, Soltero ER, Dinney CP, Walsh GL, Schrump DS, Swanson DA, Pisters LL, Willis KD, Putnam JB, Jr. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg 63:1592-1600, 1997. e-Pub 1997. PMID: 9205155.
301. Pisters LL, von Eschenbach AC, Scott SM, Swanson DA, Dinney CP, Pettaway CA, Babaian RJ. The efficacy and complications of salvage cryotherapy of the prostate. J Urol 157:921-925, 1997. e-Pub 1997. PMID: 9072600.
302. McDonnell TJ, Navone NM, Troncoso P, Pisters LL, Conti C, von Eschenbach AC, Brisbay S, Logothetis CJ. Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer. J Urol 157:569-574, 1997. e-Pub 1997. PMID: 8996359.
303. Cespedes RD, Pisters LL, von Eschenbach AC, McGuire EJ. Long-term followup of incontinence and obstruction after salvage cryosurgical ablation of the prostate: results in 143 patients. J Urol 157:237-240, 1997. e-Pub 1997. PMID: 8976261.
304. Greene, GF, Pisters, LL, von Eschenbach, AC. “modern” prostate cryotherapy. Journal of Pelvic Surgery 2(4):198-204, 1996. e-Pub 1996.
305. Sarosdy MF, Pisters LL, Carroll PR, Benson MC, Moon TD, Lamm DL, Hudson MA, Lerner SP, Koch MO, Schellhammer PF. Bropirimine immunotherapy of upper urinary tract carcinoma in situ. Urology 48(1):28-32, 1996. e-Pub 1996. PMID: 8693647.
306. Seigne JD, Pisters LL, von Eschenbach AC. Osteitis pubis as a complication of prostate cryotherapy. J Urol 156:182, 1996. e-Pub 1996. PMID: 8648793.
307. Delworth MG, Pisters LL, Fornage BD, von Eschenbach AC. Cryotherapy for renal cell carcinoma and angiomyolipoma. J Urol 155:252-255, 1996. e-Pub 1996. PMID: 7490847.
308. Greene G, Pisters LL, von Eschenbach AC. “Modern” prostate cryotherapy. J Pelvic Surg 2(4):198-204, 1996. e-Pub 1996.
309. Tanguay S, Pisters LL, Lawrence DD, Dinney CP. Therapy of locally recurrent renal cell carcinoma after nephrectomy. J Urol 155:26-29, 1996. e-Pub 1996. PMID: 7490850.
310. Pettaway CA, Pisters LL, Dinney CP, Jularbal F, Swanson DA, von Eschenbach AC, Ayala A. Sentinel lymph node dissection for penile carcinoma: the M. D. Anderson Cancer Center experience. J Urol 154:1999-2003, 1995. e-Pub 1995. PMID: 7500444.
311. Kagan J, Stein J, Babaian RJ, Joe YS, Pisters LL, Glassman AB, von Eschenbach AC, Troncoso P. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes. Oncogene 11:2121-2126, 1995. e-Pub 1995. PMID: 7478532.
312. Pisters LL, Troncoso P, Zhau HE, Li W, von Eschenbach AC, Chung LW. c-met proto-oncogene expression in benign and malignant human prostate tissues. J Urol 154:293-298, 1995. e-Pub 1995. PMID: 7539865.
313. Kleinerman DI, Troncoso P, Lin SH, Pisters LL, Sherwood ER, Brooks T, von Eschenbach AC, Hsieh JT. Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor. Cancer Res 55:1215-1220, 1995. e-Pub 1995. PMID: 7533659.
314. Kagan, J, Pisters, LL, Troncoso, P, Joe, YS, Parat, JM, Babaian, RJ, von Eschenbach, AC. Genetic instability in microsatellite sequences in prostate cancer. International journal of oncology 5(4):921-924, 1994. e-Pub 1994.
315. Kagan J, Pisters LL, Troncoso P, Joe YS, Parat JM, Babaian RJ, von Eschenbach AC. Genetic instability in microsatellite sequences in prostate cancer. Int J Oncology 5:921-924, 1994. e-Pub 1994.
316. Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, von Eschenbach AC, Chung LW, Liang JC. Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Gene Chrom 9:19-27, 1994. e-Pub 1994. PMID: 7507696.
317. Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, von Eschenbach AC, Conti CJ. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 85(20):1657-1669, 1993. e-Pub 1993. PMID: 7692074.
318. Pisters LL Wajsman Z. Use of predeposit autologous blood and intraoperative autotransfusion in urologic cancer surgery. Urology 40(3):211-215, 1992. e-Pub 1992. PMID: 1523742.
319. Pisters LL Wajsman Z. A simple test for the detection of intraoperative rectal injury in major urological pelvic surgery. J Urol 148:354, 1992. e-Pub 1992. PMID: 1635133.
320. Pisters LL, Tykochinsky G, Wajsman Z. Intravesical bacillus Calmette-Guerin or mitomycin C in the treatment of carcinoma in situ of the bladder following prior pelvic radiation therapy. J Urol 146:1514-1517, 1991. e-Pub 1991. PMID: 1942330.
321. Smallbone BW, Davies BJ, Noulty EJ, Pisters LL, Taylor NE, McDonald JW. Effects of verapamil on thromboxane synthesis and pulmonary hypertension in sheep. Clin Invest Med 9(3):145-9, 1986. e-Pub 1986. PMID: 3757320.
322. Othman M, Pisters L, Davis J. When prostate cancer remains undetectable: The dilemma , Prostat kanseri ne zaman saptanamaz olarak kalir; bir ikilen. Turkish Journal of Urology.

Invited Articles

1. Tu SM, Pisters LL. Stem-Cell Theory of Cancer: Implications for Antiaging and Anticancer Strategies. Cancers (Basel) 14(5), 2022. e-Pub 2022. PMID: 35267646.
2. Okorie CO, Pisters LL. Effect of modified suprapubic prostatectomy for benign prostatic hyperplasia on postoperative hemoglobin levels. Can J Urol 17(4):5255-8, 2010. e-Pub 2010. PMID: 20735903.
3. Leibovici D, Spiess PE, Lee AK, Pisters LL. Symptomatic Local Recurrence of Prostate Cancer After Radiation Therapy : Lessons Learned from 1006 Patients Treated at M. D. Anderson Cancer Center. The American Journal of Oncology Review 4(9):25-28, 2005. e-Pub 2005.
4. Pisters LL. Editorial contribution to UrologyHealth.org. Received Silver Award from Consumer Health Publishers Association and Online Health Association. American Urological Association, 2004. e-Pub 2004.
5. Huang S, Pisters LL. Cryotherapy for prostate cancer. UpToDate in Oncology 9(2):2001, 2001. e-Pub 2001.
6. Pisters LL. The challenge of locally advanced prostate cancer. Semin Oncol 26(2):202-216, 1999. e-Pub 1999. PMID: 10597731.
7. Nesbitt JC, Gregoric ID, Pisters LL. Renal cell carcinoma with Budd-Chiari syndrome. Contemporary Surgery 53(1):53-56, 1998. e-Pub 1998.
8. Pisters LL, Pettaway CA, Troncoso P, Finn LD, Scott SM, Logothetis CJ. Preliminary results of preoperative chemotherapy and hormonal therapy followed by radical prostatectomy for locally advanced prostate cancer. Prostate Cancer and Prostatic Diseases 1(1):15, 1998. e-Pub 1998.
9. Corral DA, Pisters LL, von Eschenbach AC. Treatment options for localized recurrence of prostate cancer following radiation therapy. Urol Clin North Am 23(4):677-684, 1996. e-Pub 1996. PMID: 8948420.
10. Pisters LL, Westney L. The management of locally recurrent invasive bladder cancer following radical cystectomy. Semin Urol Oncol 14(2):112-119, 1996. e-Pub 1996. PMID: 8734739.
11. Pisters LL, von Eschenbach AC. Technique, results, and complications of “modern” prostate cryotherapy. American Urological Association Update Series, Lesson 37 15:298-303, 1996. e-Pub 1996.
12. Pisters LL, Babaian RJ. The status of early prostate cancer detection (Part 1). Hospital Medicine:18-23, 1993. e-Pub 1993.
13. Pisters LL Babaian RJ. The status of early prostate cancer detection. Cancer Bulletin 45(5):389-396, 1993. e-Pub 1993.
14. Pisters LL, Babaian RJ. Evaluating screening tools for prostate cancer. Hospital Medicine:62-79, 1993. e-Pub 1993.

Review Articles

1. Ranasinghe, WK, Shapiro, DD, Zhang, M, Bathala, TK, Navone, NM, Thompson, T, Broom, BM, Aparicio, A, Tu, S, Tang, C, Davis, JW, Pisters, LL, Chapin, BF. Optimizing the diagnosis and management of ductal prostate cancer. Nature Reviews Urology 18(6):337-358, 2021. e-Pub 2021. PMID: 33824525.
2. Bargiota, A, Oeconomou, A, Zachos, I, Samarinas, M, Pisters, LL, Tzortzis, V. Adverse effects of androgen deprivation therapy in patients with prostate cancer. Journal of B.U.ON 25(3):1286-1294, 2020. e-Pub 2020. PMID: 32862568.
3. Siddiqui BA, Zhang M, Pisters LL, Tu SM. Systemic therapy for primary and extragonadal germ cell tumors: prognosis and nuances of treatment. Transl Androl Urol 9(Suppl 1):S56-S65, 2020. e-Pub 2020. PMID: 32055486.
4. Marra G, Valerio M, Emberton M, Heidenreich A, Crook JM, Bossi A, Pisters LL. Salvage Local Treatments After Focal Therapy for Prostate Cancer. Eur Urol Oncol 2(5):526-538, 2019. e-Pub 2019. PMID: 31412013.
5. Okorie CO, Pisters LL. Evolution of Bloodless Surgery: A Case for Bloodless Suprapubic Prostatectomy. Niger Med J 60(4):169-174, 2019. e-Pub 2019. PMID: 31831934.
6. Tzortzis, V, Samarinas, M, Zachos, I, Oeconomou, A, Pisters, LL, Bargiota, A. Adverse effects of androgen deprivation therapy in patients with prostate cancer. Hormones 16(2):115-123, 2017. e-Pub 2017. PMID: 28742500.
7. Mustafa MO, Pisters L. When prostate cancer remains undetectable: The dilemma. Turk J Urol 41(1):32-8, 2015. e-Pub 2015. PMID: 26328196.
8. Ward JF, Pisters LL. Considerations for patient selection for focal therapy. Ther Adv Urol 5(6):330-7, 2013. e-Pub 2013. PMID: 24294291.
9. Eastham JA, Carroll P, Pisters L, Nguyen PT, Touijer K. Salvage therapies after radiation therapy. Urol Oncol 30(6):940-1, 2012. e-Pub 2012. PMID: 23218071.
10. Mustafa, MO, Pisters, LL. Salvage therapies for radiorecurrent prostate cancer. Turk Uroloji Dergisi 37(4):350-356, 2011. e-Pub 2011.
11. Pisters, LL. Cryotherapy for prostate cancer. Current opinion in urology 20(3):218-222, 2010. e-Pub 2010. PMID: 20224411.
12. Raz, O, Pisters, LL, Spiess, PE, Lindner, A, Leibovici, D. Palliative surgery for locally advanced prostate cancer. HAREFUAH 148(8):535-538, 2009. e-Pub 2009. PMID: 19899258.
13. Gorbatiy, V, Spiess, PE, Pisters, LL. The growing teratoma syndrome. Indian Journal of Urology 25(2):186-189, 2009. e-Pub 2009. PMID: 19672343.
14. Babaian, RJ, Donnelly, JB, Bahn, D, Baust, JG, Dineen, M, Ellis, D, Katz, AE, Pisters, LL, Rukstalis, D, Shinohara, K, Thrasher, JB. Best Practice Statement on Cryosurgery for the Treatment of Localized Prostate Cancer. Journal of Urology 180(5):1993-2004, 2008. e-Pub 2008. PMID: 18817934.
15. Leibovici, D, Spiess, PE, Heller, L, Rodriguez-Bigas, MA, Chang, GJ, Pisters, LL. Salvage surgery for locally recurrent prostate cancer after radiation therapy. Urologic Oncology: Seminars and Original Investigations 26(1):9-16, 2008. e-Pub 2008. PMID: 18190824.
16. Leibovici, D, Spiess, PE, Agarwal, PK, Tu, S, Pettaway, CA, Hitzhusen, K, Millikan, RE, Pisters, LL. Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level. Cancer 109(2):198-204, 2007. e-Pub 2007. PMID: 17171704.
17. Pendleton, J, Pisters, LL, Nakamura, K, Anai, S, Rosser, CJ. Neoadjuvant therapy before radical prostatectomy. Urologic Oncology: Seminars and Original Investigations 25(1):11-18, 2007. e-Pub 2007. PMID: 17208133.
18. Spiess, PE, Leibovici, D. Surgery for locally advanced disease. Current Prostate Reports 4(2):59-66, 2006. e-Pub 2006.
19. Spiess PE, Leibovici D, Pisters LL. Surgery for locally advanced disease. Curr Urol Rep 7(3):209-216, 2006. e-Pub 2006. PMID: 16630524.
20. Kamat AM, Shock RP, Naya Y, Rosser CJ, Slaton JW, Pisters LL. Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors. Urology 63:46-50, 2004. e-Pub 2004. PMID: 14751346.
21. Bermejo CE, Pisters LL. Cryotherapy for prostate cancer. Expert Rev Anticancer Ther 3:393-401, 2003. e-Pub 2003. PMID: 12820781.
22. Pisters LL. Salvage radical prostatectomy: refinement of an effective procedure. Semin Radiat Oncol 13:166-174, 2003. e-Pub 2003. PMID: 12728446.
23. Izawa JI, Perrotte P, Greene GF, Scott S, Levy L, McGuire E, Madsen L, von Eschenbach AC, Pisters LL. Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy. J Urol 165:867-870, 2001. e-Pub 2001. PMID: 11176488.
24. Sweeney P, Pisters LL. Ad5CMVp53 gene therapy for locally advanced prostate cancer--where do we stand?. World J Urol 18:121-124, 2000. e-Pub 2000. PMID: 10854146.
25. Slaton JW, Balbay MD, Levy DA, Pisters LL, Nesbitt JC, Swanson DA, Dinney CP. Nephrectomy and vena caval thrombectomy in patients with metastatic renal cell carcinoma. Urology 50(5):673-677, 1997. e-Pub 1997. PMID: 9372873.
26. Chen ME, Pisters LL, Malpica A, Pettaway CA, Dinney CP. Risk of urethral, vaginal and cervical involvement in patients undergoing radical cystectomy for bladder cancer: results of a contemporary cystectomy series from M. D. Anderson Cancer Center. J Urol 157:2120-2123, 1997. e-Pub 1997. PMID: 9146596.
27. Zhau HE, Pisters LL, Hall MC, Zhao LS, Troncoso P, Pollack A, Chung LW. Biomarkers associated with prostate cancer progression. J Cell Biochem Suppl 19:208-216, 1994. e-Pub 1994. PMID: 7529853.
28. Pisters, LL, Babaian, RJ. Status of early prostate cancer detection. Cancer Bulletin 45(5):389-396, 1993. e-Pub 1993.

Professional Educational Materials

1. Pisters LL. Audio Series – “Topics in Urology Audio Series,” Sponsored by the American Urological Association Education and Research, Inc.® Office of Education. Oakstone Medical Publishing, 2006.
2. Pisters LL. Audio Series – “The AUA’s Topics in Urology Audio Series,” Sponsored by the American Urological Association Education and Research, Inc.® Office of Education. Oakstone Medical Publishing, 2004.
3. Pisters LL. Postgraduate Course – “Biological Basis for Application of Mechanism-Based Therapy in Prostate Cancer,” American Urological Association 2003 Annual Meeting, Chicago, IL, 2003.
4. Pisters LL. Postgraduate Course – “Management and Treatment of Advanced Carcinoma of the Prostate,” American Urological Association 95th Annual Meeting, Orlando, FL, 2002.
5. Pisters LL. Postgraduate Course – “Rising Prostate-specific Antigen Level After Local Therapy for prostate cancer: Patient evaluation and treatment options.” American Society of Clinical Oncology 36th Annual Meeting, New Orleans, LA, 2000.
6. Pisters LL. Postgraduate Course – “Management and Treatment of Advanced Carcinoma of the Prostate,” American Urological Association 95th Annual Meeting, Atlanta, GA, 2000.
7. Pisters LL. Postgraduate Course -- “Management and Treatment of Advanced Carcinoma of the Prostate,” American Urological Association 94th Annual Meeting, Dallas, TX, 1999.
8. Pisters LL. Postgraduate Course -- “Management and Treatment of Advanced Carcinoma of the Prostate,” American Urological Association 93rd Annual Meeting, San Diego, CA, 1998.
9. Pisters LL. Postgraduate Course -- “Management and Treatment of Advanced Carcinoma of the Prostate,” American Urological Association 92nd Annual Meeting, New Orleans, LA, 1997.
10. Pisters LL. Director, Postgraduate Course -- "Cryoablation of the Prostate," American Urological Association 91st Annual Meeting, Orlando, FL, 1996.
11. Pisters, LL, von Eschenbach AC. Technique, results, and complications of ‘modern’ prostate cryotherapy.” American Urological Association Update Series, Lesson 37, 1996.

Other Articles

1. Okorie, CO, Salia, M, Liu, P, Pisters, LL Reply. Urology 75(3):705-706, 2010.
2. Pisters, LL Editorial Comment. Urology 72(6):1314, 2008.
3. Pisters, LL Results of salvage cryoablation of the prostate after radiation. Journal of Urology 165(6 I):1941-1942, 2001.
4. Montie, JE, Pisters, LL Editorial comments. Journal of Urology 166(4):1337-1338, 2001.
5. Pisters LL The challenge of locally advanced prostate cancer. Semin Oncol 26(2):202-16, 1999.
6. Pisters, LL Transurethral resection with perioperative instillation of interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer. Journal of Urology 161(4 SUPPL):1135, 1999.
7. Spiess PE, Huang S, Pisters LL Cryotherapy in prostate cancer. Uptodate (online medical book: http:www.uptodate.com).

Editorials

1. Pisters, LL. Treatment failure after primary and salvage therapy for prostate cancer. Cancer 112(2):225-227, 2008. PMID: 18050293.
2. Pisters LL. Commentary on Cryosurgical Ablation of the Prostate for Prostate Cancer: Background, Technique, and Results, in Pantuck AJ, Zisman A, Belldegrun. Management of Prostate Cancer Advances and Controversies. New York, Marcel Dekker:278-281, 2005.
3. Pisters LL. Prostate cancer--adjusting the tiller. J Urol 155:1678-1680, 1996. PMID: 8627852.

Abstracts

1. Parker PA, Latini DM, Ward JF, Pettaway CA, Pisters LL, Matin SF, Frank SJ, Brown V, Kuban DA, Logothetis CJ, Kim J, Davis JW. Associations Between Uncertainty, Anxiety, and Quality of Life in Men with Prostate Cancer on Active Surveillance. Annals of Behavioral Medicine 37 (Suppl) 37, 2009. e-Pub 2009.
2. Spiess PE, Brown GO, Pettaway CA, Gomez JA, Evans J, Kassouf W, Black P, Kamat AM, Pisters LLP. Malignant transformation of testicular teratoma: A chemoresistant phenotype. American Urological Association 2006 Annual Meeting, Atlanta, GA. J Urol 455:147, 2006. e-Pub 2006.
3. Sanda MG, Dunn RL, Northouse L, Litwin MS, Hembroff L, Sandler HM, Jeff M, Klein EA, Saigal CS, Pisters LL, Kuban DA, Kaplan I, Wei JT. Prostate cancer physician performance measured by patient-reported ratings of practitioner manner/skill and by treatment-related adverse events. American Urological Association 2006 Annual Meeting, Atlanta, GA. J Urol 1605:517, 2006. e-Pub 2006.
4. Hu JC, Wood DP, Andriole GL, Dunn RL, Dahl DM, Hollenbeck BK, Kibel AS, Saigal CS, Litwin MS, Pisters LL, Klein EA, Montie LE, Wei JT, Sanda MG. Perioperative quality care indicators of retropubic, laparoscopic, and robotic prostatectomy: Results from a national, multi-center, prospective cohort. American Urological Association 2006 Annual Meeting, Atlanta, GA. J Urol 1151:370, 2006. e-Pub 2006.
5. Spiess PE, Busby JE, Jordan J, Hernandez M, Troncoso P, Burt KL, Lee AK, Taylor SH, Merrimen KW, Bassett RR, Pisters LL. Radical prostatectomy for lymph node positive prostate cancer: The MDACC experience. American Urological Association 2006 Annual Meeting, Atlanta, GA. J Urol 966:311, 2006. e-Pub 2006.
6. Pettaway CA, Pisters LL, Troncoso P, Wang R, Brown GO, Busby JE, Spiess PE, Millikan RE, Logothetis CJ. Clinical aspects of the high risk neoadjuvant treatment model: Five year results. American Urological Association 2006 Annual Meeting, Atlanta, GA. J Urol 962:310, 2006. e-Pub 2006.
7. Spiess PE, Brown GO, Liu P, Evans J, Kamat AM, Pisters LL. Recurrence pattern and proposed surveillance protocol in patients following post-chemotherapy retroperitoneal lymph node dissection. American Urological Association 2006 Annual Meeting, Atlanta, GA. J Urol 595:192, 2006. e-Pub 2006.
8. Spiess PE, Kassouf W, Brown GO, Kamat AM, Gomez JA, Evans J, Pisters LL. MDACC experience in the clinical management of growing teratoma syndrome. American Urological Association 2006 Annual Meeting, Atlanta, GA. J Urol 448:145, 2006. e-Pub 2006.
9. Sanda MG, Dunn RL, Arbor A, Saigal CS, Klein EA, Pisters LL, Michalski JM, Kibel AS, Madadevan A, Sandler HM, Kuban DA, Litwin MS, Wei JT, Arbor A. Association of race, cancer severity, pre-treatment quality of life, and patient optimism/pessimism with patient selection of primary prostate cancer treatment. American Urological Association 2005 Annual Meeting, San Antonio, TX 1671:453, 2005. e-Pub 2005.
10. Sanda MG, Dunn RL, Arbor A, Mahadevan A, Sandler HM, Arbor A, Saigal CS, Kuban DA, Michalski JM, Pisters LL, Klein EA, Kibel AS, Litwin MS, Hembroff L, Wei JT, Arbor A. Neoadjuvant hormone therapy (NHT) leads to immediate impairment of vitality/hormonal and sexual quality of life: Results of a multi-center prospective study. American Urological Association 2005 Annual Meeting, San Antonio, TX 824:223, 2005. e-Pub 2005.
11. Leibovici D, Lee AK, Cheung RM, Kuban DA, Rosser CJ, Chichakli R, Pisters LL. Symptomatic local recurrence of prostate cancer after radiation therapy. American Urological Association 2005 Annual Meeting, San Antonio, TX 694:189, 2005. e-Pub 2005.
12. Leibovici D, Kassouf W, Kamat AM, Pisters LL, Pettaway CA, Dinney CPN. Transurethral tumor resection versus partial cystectomy for bladder preservation for muscle invasive cancer. American Urological Association 2005 Annual Meeting, San Antonio, TX 1119:303, 2005. e-Pub 2005.
13. Spiess PE, Evans J, Kamat AM, Wood CG, Pettaway CA, Dinney CPN, Pisters LL. Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: review of the University of Texas M. D. Anderson Cancer Center experience. American Urological Association 2005 Annual Meeting, San Antonio, TX 725:197, 2005. e-Pub 2005.
14. Kassouf W, Leibovici D, Zhou X, Dinney CPN, Barton GH, Siefer-Radtke AO, Pisters LL, Swanson DA, Kamat AM. Significance of lymph node positive disease in patients treated with neoadjuvant chemotherapy: Is adjuvant chemotherapy beneficial? American Urological Association 2005 Annual Meeting, San Antonio, TX 1317:358, 2005. e-Pub 2005.
15. Kamat AM, Rosser CJ, Wen S, Cheung RM, Lee AK, Putman S, Pisters LL. Body mass index does not affect outcome for men undergoing external-beam radiotherapy for localized prostate cancer. American Urological Association 2005 Annual Meeting, San Antonio, TX 1033:280, 2005. e-Pub 2005.
16. Kamat AM, Gee JR, Grossman BH, Dinney CPN, Siefer-Radtke AO, Millikan RE, Swanson DA, Robinson TL, Pisters LL. Micropapillary transitional cell carcinoma of the bladder: A retrospective review of the experience with 100 consecutive patients. American Urological Association 2005 Annual Meeting, San Antonio, TX 1113:302, 2005. e-Pub 2005.
17. Kamat AM, Gee JR, Dinney CPN, Grossman BH, Swanson DA, Millikan RE, Robinson TL, LL: P. The case for early cystectomy in non-muscle-invasive micropapillary transitional cell carcinoma of the bladder. American Urological Association 2005 Annual Meeting, San Antonio, TX 915:247, 2005. e-Pub 2005.
18. De E, Pisters LL, Pettaway CA, Scott SM, Westney OL. Salvage prostatectomy with bladder neck closure and continent catheterizable bladder augmentation: 31-month follow-up by patient report and incontinence symptom index. American Urological Association 2005 Annual Meeting, San Antonio, TX 283:78, 2005. e-Pub 2005.
19. Bochner BH, Uzzo RG, Sokoloff M, Pisters LL, Matin SF, Sanda MG, Arbor A, Colberg J, Wood CG, Konety BR, Penson DF. Current status of clinical trials in urothelial cancers: A summary from the ACOSOG GU working group. American Urological Association 2005 Annual Meeting, San Antonio, TX 1327:360, 2005. e-Pub 2005.
20. Siefker-Radtke AO, Dinney CP, Abrahams NA, Pisters LL, Grossman HB, Swanson DA, Millikan RE. Is there a role for pre-operative chemotherapy in small cell bladder carcinoma? The M. D. Anderson experience. American Urological Association 2003 Annual Meeting, Chicago, IL. J Urol 169:1300A, 2003. e-Pub 2003.
21. Izawa JI, Morganstern N, Chan DM, Levy LB, Scott S, Pisters LL. Incomplete glandular ablation following salvage cryotherapy for recurrent prostate cancer following radiotherapy. American Urological Association 2003 Annual Meeting, Chicago, IL. J Urol 169:936A, 2003. e-Pub 2003.
22. Kamat AM, Rosser CJ, Levy LB, Chichakli R, Pisters LL. Fluctuation of ³0.5 ng/ml in serum PSA more than 2 years after external-beam radiotherapy predicts for biochemical failure. American Urological Association 2003 Annual Meeting, Chicago, IL. J Urol 169:1719A, 2003. e-Pub 2003.
23. Rosser CJ, Levy LB, Kuban DA, Chichakli R, Pollack A, Lee A, Pisters LL. Hazard rates of disease progression after external-beam radiotherapy for clinically localized carcinoma of the prostate. American Urological Association 2003 Annual Meeting, Chicago, IL. J Urol 169:695A, 2003. e-Pub 2003.
24. Tanaka M, Rosser CJ, Tanaka N, Grossman HB, Kuban DA, Meyn RE, Pisters LL. Adenoviral-mediated PTEN transgene expression sensitizes radio-resistant prostate cancer cell in vitro to radiation. American Urological Association 2003 Annual Meeting, Chicago, IL. J Urol 169:857A, 2003. e-Pub 2003.
25. Slaton JW, Kedar D, Balbay MD, Dinney CP, Wood CG, Pisters LL, Swanson DA. Impact of rising rates of obesity on morbidity of radical nephrectomy. American Urological Association 2002 Annual Meeting, Orlando, FL. J Urol 167:782A, 2002. e-Pub 2002.
26. Sweeny P, Slaton JW, Munsell M, Carpenter S, Vaporciyan A, Swanson DA, Wood CG, Pisters L, Dinney CP. An analysis of prognostic factors for patients with renal cancer extending into the vena cava. American Urological Association 2002 Annual Meeting, Orlando, FL. J Urol 167:777A, 2002. e-Pub 2002.
27. Sweeney P, Millikan RE, Wood CG, Pettaway CA, Donat M, Grossman B, Pisters LL. Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection (RPLND) in metastatic transitional cell carcinoma (TCC) of the bladder? American Urological Association 2002 Annual Meeting, Orlando, FL. J Urol 167:1117A, 2002. e-Pub 2002.
28. Scott SM, Leibovich B, Izawa JI, Blute ML, Madsen L, von Eschenbach AC, Slezak JM, Zincke H, Pisters LL. A comparison of biochemical outcome following salvage prostatectomy or cryosurgery for locally recurrent prostate cancer after radiation therapy. South Central Section of the American Urological Association, 81st Annual Meeting, Colorado Springs, CO 33:172, 2002. e-Pub 2002.
29. Scott SM, Izawa JI, Morgenstern N, Chan DM, Levy LB, Pisters LL. Variables associated with incomplete glandular ablation following salvage cryotherapy for recurrent prostate cancer following radiotherapy. South Central Section of the American Urological Association, 81st Annual Meeting, Colorado Springs, CO 35:174, 2002. e-Pub 2002.
30. Rosser CJ, Kuban DA, Levy LB, Chichakli R, Pollack A, Lee A, Pisters LL. The PSA “bounce” phenomena after external beam radiation for clinically localized prostate cancer. American Urological Association 2002 Annual Meeting, Orlando, FL. J Urol 167:1556A, 2002. e-Pub 2002.
31. Pisters LL, Pettaway CA, Troncoso P, McDonnell TJ, Stephens C, Wood CG, K-A D, Brisbay SM, Wang X, Hossan EA, Evans RB, Soto CP, Fenstermacher MJ, Parker K, Merritt JA, Steiner MS, Logothetis CJ. Evidence that transfer of functional p53 protein results in increased apoptosis in prostate cancer. American Urological Association 2002 Annual Meeting, Orlando, FL. J Urol 167:1335A, 2002. e-Pub 2002.
32. Min R, Sexton WJ, Wood CG, Pisters LL. Repeat retroperitoneal lymph node dissection for metastatic testis cancer. South Central Section of the American Urological Association, 81st Annual Meeting, Colorado Springs, CO 128:265, 2002. e-Pub 2002.
33. Huang S, Swanson D, Pisters L, von Eschenbach A, Babaian R, Chang D, Wood CG. Contralateral sural nerve grafting (SNG) after unilateral nerve sparing radical prostatectomy (RP) improves post-operative potency rates. American Urological Association 2002 Annual Meeting, Orlando, FL. J Urol 167:1365A, 2002. e-Pub 2002.
34. Gee JR, Kent DS, Millikan RE, Dinney CP, Grossman HB, Pisters LL. Micropapillary bladder carcinoma: Preliminary results of BCG and neoadjuvant chemotherapy. American Urological Association 2002 Annual Meeting, Orlando, FL. J Urol 167:1031A, 2002. e-Pub 2002.
35. Boelter CW, Pisters L, Gettman M, Sweeney P, Weaver A, Lohse C, Carpenter S, Dinney C, Cheville JC, Zincke H, Blute ML. Renal cell carcinoma with extension to the right atrium: Prognostic factors and long-term follow-up of the Mayo Clinic and M. D. Anderson experience. American Urological Association 2002 Annual Meeting, Orlando, FL. J Urol 167:785A, 2002. e-Pub 2002.
36. Scott S, Izawa J, Pisters LL, Madsen L, von Eschenbach AC. Salvage cryotherapy for locally recurrent prostate cancer following radiation therapy: Variables impacting patient survival. South Central Section of the American Urological Association, 80th Annual Meeting, Austin, TX 20:154, 2001. e-Pub 2001.
37. Sexton WJ, Lance RE, Reyes AO, Pisters PWT, S-M T, Pisters LL. Adult prostate sarcomas: The M. D. Anderson Cancer Center experience. South Central Section of the American Urological Association, 80th Annual Meeting, Austin, TX 13:147, 2001. e-Pub 2001.
38. Rosser CJ, Smith LG, Chichakli R, Levy LB, Pollack A, Kuban DA, Pisters L. The effects of age on biochemical disease progression in men with carcinoma of the prostate treated with external beam irradiation. J Urol 165:1363A, 2001. e-Pub 2001.
39. Pisters LL, Pettaway CA, McDonnell TJ, Troncoso P, Brisbay SM, Wood CG, Stephens LC, Hossan EA, Evans RB, Fenstermacher MJ, Parker K, Merritt JA. Evidence that transfer of functional p53 protein results in increased apoptosis in prostate cancer. South Central Section of the American Urological Association, 80th Annual Meeting, Austin, TX 14:148, 2001. e-Pub 2001.
40. Pisters L, Leibovich B, Izawa J, Blute M, Madsen L, Scott S, von Eschenbach A, Slezak J, Zincke H. A comparison of biochemical outcome following salvage prostatectomy or cryosurgery for locally recurrent prostate cancer after radiation therapy. American Society for Therapeutic Radiology and Oncology 43rd Annual Meeting, San Francisco, CA 2135, 2001. e-Pub 2001.
41. Leibovich BC, Zincke H, Blute ML, Slezak JM, Izawa J, Madsen L, Scott S, von Eschenbach AC, Pisters LL. Recurrent prostate cancer after radiation therapy: Salvage prostatectomy versus salvage cryosurgery. American Urological Association 96th Annual Meeting, Anaheim, CA. J Urol 165:1595A, 2001. e-Pub 2001.
42. Kim R, Sexton WJ, Wood CG, Pisters LL. Repeat retroperitoneal lymph node dissection for metastatic testis cancer. American Urological Association 96th Annual Meeting. Anaheim, CA. J Urol 165:628A, 2001. e-Pub 2001.
43. Kedar D, Izawa J, Tamboli P, Ainslie N, Eddings T, Babaian RJ, Dinney CPN, Pisters LL, Pettaway CA. Intraoperative lymphatic mapping (IOLM) for squamous penile cancer: The M. D. Anderson Cancer Center prospective experience. American Urological Association 96th Annual Meeting, Anaheim, CA. J Urol 165:711A, 2001. e-Pub 2001.
44. Izawa JI, Madsen L, Scott S, von Eschenbach A, Pisters L. Long term follow-up of salvage cryotherapy for locally recurrent prostate cancer following radiation therapy. American Urological Association 96th Annual Meeting, Anaheim, CA. J Urol 165:1359A, 2001. e-Pub 2001.
45. Izawa J, Pisters LL, Madsen L, Scott S, von Eschenbach AC. Salvage cryotherapy for locally recurrent prostate cancer following radiation therapy: Variables impacting patient survival. American Society of Clinical Oncology 37th Annual Meeting, San Francisco, CA. Proceedings of the American Society of Clinical Oncology 20:760A, 2001. e-Pub 2001.
46. Pisters LL, McDonnell TJ, Troncoso P, Brisbay S, Hossan E, Pettaway C, Wood C, Evans R, Steiner M, Merritt J, Logothetis C. Intraprostatic Ad-p53 gene therapy induces apoptosis in locally advanced adenocarcinoma of the prostate. American Society of Clinical Oncology 37th Annual Meeting, San Francisco, CA. Proceedings of the American Society of Clinical Oncology 20:699A, 2001. e-Pub 2001.
47. English SF, Scott SM, Pisters LL, McGuire EJ. The development of continence following radical prostatectomy for adenocarcinoma of the prostate. American Urological Association 95th Annual Meeting, Atlanta, GA. J Urol 163:1291A, 2000. e-Pub 2000.
48. Pisters LL, Westney OL, Scott S, Swanson DA, McGuire EJ. Pubourethral sling simultaneous with radical retropubic prostatectomy for patients at high risk for postprostatectomy incontinence. South Central Section of the American Urological Association 79th Annual Meeting, Montreal, Quebec, Canada 87:215, 2000. e-Pub 2000.
49. Daliani DD, Logothetis CJ, Pettaway CA, Meyers CA, Pisters LL, Coursen C, Davies K, Troncoso P, Reyes A. TNP-470 therapy preceding radical prostatectomy (RP): A model for assessment of safety and biologic activity of angiogenesis inhibitors. American Society of Clinical Oncology 36th Annual Meeting, New Orleans, LA. Proceedings of the American Society of Clinical Oncology 19:376A, 2000. e-Pub 2000.
50. Perrotte P, Tran J, McGuire EJ, Pisters LL. Effect of prior therapy on survival after salvage cryotherapy for recurrent prostate cancer. Prostate Cancer Prostatic Dis 2(3):S25, 1999. e-Pub 1999. PMID: 12496804.
51. Pisters LL, Pettaway CA, Hossan E, Evans R, Steiner MS, Wood CG, Troncoso P, McDonnell TJ, Fenstenmacher MJ, Logothetis CJ. Intraprostatic AD-p53 gene therapy followed by radical prostatectomy: feasibility and preliminary results. Prostate Cancer Prostatic Dis 2(3):S27, 1999. e-Pub 1999. PMID: 12496806.
52. Pisters LL, Perrotte P, Greene GF, Scott SM, Tran JP, von Eschenbach AC. Salvage cryotherapy for recurrent prostate cancer following radiation therapy: variables impacting local tumor control. South Central Section of the American Urological Association 78th Annual Meeting, Santa Fe, NM 37:157, 1999. e-Pub 1999.
53. Tran JP, McGuire EJ, Greene GF, Westney OL, Perrotte P, Scott SM, von Eschenbach AC, Pisters LL. Salvage cryotherapy for recurrent prostate cancer following radiation therapy: The effect of prior therapy on patient survival. American Urological Association 94th Annual Meeting, Dallas, TX. J Urol 161:676A, 1999. e-Pub 1999.
54. von Eschenbach AC, Perrotte P, Greene GF, Scott S, Tran JP, Pisters LL. Salvage cryotherapy for recurrent prostate cancer following radiation therapy: Variables impacting local tumor control. American Urological Association 94th Annual Meeting, Dallas, TX. J Urol 161:1381A, 1999. e-Pub 1999.
55. Logothetis CJ, Hossan E, Pettaway CA, Evans R, Steiner MS, Wood CG, Troncoso P, McDonnell TJ, Fenstenmacher MJ, Pisters LL. AD-p53 intraprostatic gene therapy preceding radical-prostatectomy (RP): An in vivo model for targeted therapy development. . J Urol 161:1142A, 1999. e-Pub 1999.
56. Pettaway CA, Jularbal FE, Babaian RJ, Dinney CPN, Pisters LL. Intraoperative lymphatic mapping to detect inguinal metastases in penile carcinoma: Results of a pilot study. American Urological Association 94th Annual Meeting, Dallas, TX. J Urol 161:612A, 1999. e-Pub 1999.
57. Pettaway CA, Pisters LL, Troncoso P, Finn LD, Slaton JW, Logothetis CJ. Preoperative chemotherapy (CHT) and hormonal therapy (AA) followed by radical prostatectomy (RP) for locally advanced prostate cancer (PCA). American Urological Association 94th Annual Meeting, Dallas, TX. J Urol 161:1293A, 1999. e-Pub 1999.
58. Pisters LL, English SF, Dinney CPN, McGuire EJ. Salvage prostatectomy with continent catheterizable urinary reconstruction: A novel approach to recurrent prostate cancer following radiation therapy. . J Urol 161:1293A, 1999. e-Pub 1999.
59. Pisters LL, English SF, Dinney CPN, McGuire EJ. Continent catheterizable urinary reconstruction in patients undergoing salvage prostatectomy. South Central Section of the American Urological Association 78th Annual Meeting, Santa Fe, NM 38:158, 1999. e-Pub 1999.
60. Logothetis CJ, Hossan E, Evans R, Pettaway CA, Steiner MS, Gingrich J, Wood CG, Troncoso P, McDonnell TJ, Proksch S, Doerksen L, Merritt J, Fenstenmacher MJ, Pisters LL. Ad5CMV-p53 intraprostatic gene therapy preceding radical prostatectomy (RP): An in vivo model for targeted therapy development. American Society of Clinical Oncology 35th Annual Meeting, Atlanta, GA. Proceedings of the American Society of Clinical Oncology 18:1203A, 1999. e-Pub 1999.
61. Pisters LL, Pettaway CA, Troncoso P, Finn LD, Slaton JW, Logothetis CJ. Preoperative chemotherapy (CHT) and hormonal therapy (AA) followed by radical prostatectomy (RP) for locally advanced prostate cancer (PCA). American Society of Clinical Oncology 35th Annual Meeting, Atlanta, GA. Proceedings of the American Society of Clinical Oncology 18:1212A, 1999. e-Pub 1999.
62. Pisters LL, Levy DA, Cromeens DM, Stephens LC, von Eschenbach AC. Transrectal ultrasound-guided intraprostatic injection of absolute ethanol with and without carmustine: a feasibility study in the canine model. South Central Section of the American Urological Association 77th Annual Meeting, Cancun, Mexico 41:151, 1998. e-Pub 1998.
63. Pisters LL, Pettaway CA, Troncoso P, Finn LD, Scott SM, CJ: L. Preliminary results of preoperative chemotherapy and hormonal therapy followed by radical prostatectomy (RP) for locally advanced prostate cancer (PCA). South Central Section of the American Urological Association 77th Annual Meeting, Mexico 70:180, 1998. e-Pub 1998.
64. Swanson DA, von Eschenbach AC, Babaian RJ, Dinney CPN, Pisters LL, Pettaway CA. Is retroperitoneal lymph node dissection (RLND) alone optimal or sufficient therapy for clinical stage I nonseminomatous germ cell testicular tumors (NSGCTT) at high risk for relapse? American Urological Association 93rd Annual Meeting, San Diego, CA. J Urol 159:179A, 1998. e-Pub 1998.
65. Inoue K, Slaton JW, Perrotte P, El-Naggar AK, Pisters LL, Swanson DA, Dinney CPN. The relationship of hepatocyte growth factor receptor (C-MET) to metastasis and progression in primary and metastatic renal cell carcinoma (RCC). American Urological Association 93rd Annual Meeting, San Diego, CA. . J Urol 159:754A, 1998. e-Pub 1998.
66. McGuire EJ, English SF, Scott S, Pisters LL. The development of continence following radical prostatectomy for adenocarcinoma of the prostate. American Urological Association 93rd Annual Meeting, San Diego, CA. J Urol 159:230A, 1998. e-Pub 1998.
67. Pisters LL, Corral DA, Varma DG, Jackson EF, Amato RJ, Donat SM. Magnetic resonance imaging and magnetic resonance angiography prior to post-chemotherapy retroperitoneal lymph node dissection. American Urological Association 93rd Annual Meeting, San Diego, CA. J Urol 159:182A, 1998. e-Pub 1998.
68. Westney OL, Dinney CPN, Pisters LL, Pollack A, Millikan R, Pettaway CA. Therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder. American Urological Association 92nd Annual Meeting, New Orleans, LA. J Urol 157:994A, 1997. e-Pub 1997.
69. Pisters LL, El-Naggar AK, Weiping L, Malpica A, S-H L. The relationship between C-met proto-oncogene expression and grade in human renal cell carcinoma. South Central Section of the American Urological Association 76th Annual Meeting, Bermuda. J Urol 70:192, 1997. e-Pub 1997.
70. Pisters LL, El-Naggar AK, Luo W, Malpica A, S-H L. C-met proto-oncogene expression in benign and malignant human renal tissues. American Urological Association 92nd Annual Meeting, New Orleans, LA. J Urol 157:1080A, 1997. e-Pub 1997.
71. Pisters LL. Case Presentation - Twenty-one-year-old man with primary retroperitoneal germ cell tumor. South Central Section of the American Urological Society 76th Annual Meeting, Bermuda. J Urol 70:75, 1997. e-Pub 1997.
72. Morgenstern N, Pisters LL, Ro JY, Batts P, Ayala A, von Eschenbach AC. Histologic changes over time after salvage prostate cryotherapy. American Urological Association 92nd Annual Meeting, New Orleans, LA. J Urol 157:903A, 1997. e-Pub 1997.
73. Greene GF, Pisters LL, Scott SM, von Eschenbach AC. Predictive value of prostate specific antigen (PSA) nadir following salvage cryotherapy. American Urological Association 92nd Annual Meeting, New Orleans, LA. J Urol 157:1633A, 1997. e-Pub 1997.
74. Kleinerman DI, Troncoso P, Pisters LL, Navone NM, Hsieh JT, Logothetis CJ, von Eschenbach AC, HFBM S, Schroder FH, Trapman J. Expression and structure of the androgen receptor in bone metastases of hormone refractory prostate cancer. American Urological Association 91st Annual Meeting, Orlando, FL. J Urol 155:1254A, 1996. e-Pub 1996.
75. Pisters LL, Scott SM, Swanson DA, Babaian RJ, Dinney CPN, Pettaway CA, von Eschenbach AC. Which patients with locally recurrent prostate cancer can be cured by salvage cryotherapy?. American Urological Association 91st Annual Meeting, Orlando, FL. J Urol 155:1343A, 1996. e-Pub 1996.
76. Pisters LL, Scott SM, Swanson DA, Babaian RJ, Dinney CPN, Pettaway CA, von Eschenbach AC. The use of pretreatment factors to predict PSA outcome following salvage cryotherapy. J Urol 77:199, 1996. e-Pub 1996.
77. Pisters LL, Troncoso P, Dinney CPN, von Eschenbach AC. Feasibility study of cryotherapy followed by radical prostatectomy for locally advanced prostate cancer. American Urological Association 91st Annual Meeting, Orlando, FL. J Urol 155:989A, 1996. e-Pub 1996.
78. Sarosdy MF, Pisters LL, Carroll PR, Benson MC, Moon TD, Lamm DL, Hudson MA, Lemer SP, Koch MO, Graham SD, Schellhammer PF. Bropirimine is active against upper tract cytology positive for transitional cell cancer (TCC). American Urological Association 91st Annual Meeting, Orlando, FL. J Urol 155:729A, 1996. e-Pub 1996.
79. von Eschenbach AC, Scott SM, Swanson DA, Babaian RJ, Dinney CPN, Pettaway CA, Pisters LL. Quality of life after salvage cryotherapy for locally recurrent prostate cancer. American Urological Association 91st Annual Meeting, Orlando, FL. J Urol 155:506A, 1996. e-Pub 1996.
80. Cespedes RD, Pisters LL, von Eschenbach AC, Diaz E, McGuire EJ. Long term follow-up of incontinence after salvage cryosurgical ablation of the prostate: results in 143 patients. American Urological Association 91st Annual Meeting, Orlando, FL. J Urol 155:589A, 1996. e-Pub 1996.
81. Chen ME, Malpica A, Dinney CP, Pisters LL. Risk of urethral, vaginal, and cervical involvement in patients undergoing radical cystectomy for bladder cancer: A retrospective review of patients at M. D. Anderson Cancer Center. American Urological Association 91st Annual Meeting, Orlando, FL. J Urol 155:1263A, 1996. e-Pub 1996.
82. Greene GF, Pisters LL, Troncoso P, Dinney CPN, von Eschenbach AC. Feasibility study of cryotherapy followed by radical prostatectomy for locally advanced prostate cancer. 51st Annual Meeting of the Canadian Urological Association, Victoria, BC. Can J Urol 3(2):59A, 1996. e-Pub 1996.

Book Chapters

1. Bailey, CM, Klein, GT, Pedersen, J, Pisters, LL, Selber, JC. Robotic Harvest of the Rectus Abdominis Muscle, 29-43, 2021.
2. Pisters, LL. Essential urology, 397-441, 2017.
3. Pisters LL. Essential Urology. In: Global Surgery, 2017.
4. Pisters, LL. Prostate sarcomas and squamous cell carcinomas, 219-230, 2016.
5. Spiess PE, Leibovici D, Pisters LL. Retroperitoneal Tumors. In: Urology. 11th. Campbell-Walsh, 1403-1413, 2016.
6. Pisters LL. Prostate Sarcomas and Squamous Cell Carcinomas. In: Rare Genitourinary Tumors. Springer, 219-230, 2016.
7. Pisters, LL. Prostate cancer, 141-154, 2012.
8. Okorie, CO, Pisters, LL. Suprapubic prostatectomy for benign prostatic hyperplasia, 31-47, 2012.
9. Miller DC, Pisters LL, Belldegrun AS. Cryotherapy for Prostate Cancer. In: Urology. 10th. Campbell-Walsh, 2873-2896, 2012.
10. Leibovici, D, Pisters, LL. Cryotherapy as salvage therapy for prostate cancer, 227-231, 2008.
11. Leibovici D, Spiess PE, Pisters LL. Rectal Wall Invasion of Locally Advanced Prostate Cancer: Comparison of Magnetic Resonance Imaging with Transrectal Ultrasound. In: Cancer Imaging. Elsevier Science/Academic Press, 637-640, 2008.
12. Leibovici, D, Spiess, PE, Pisters, LL. Rectal Wall Invasion of Locally Advanced Prostate Cancer, 637-640, 2007.
13. Lam JS, Pisters LL, Belldegrun AS. Cryotherapy for Prostate Cancer. In: Urology. Ninth. Campbell-Walsh, 3032-3052, 2007.
14. Redman BG, Hurwitz M, Spiess PE, Pisters LL. Urothelial and Kidney Cancers. In: Cancer Management: A Multidisciplinary Approach. 10. CMP Healthcare Medica, 423-440, 2007.
15. Spiess PE, Leibovici D, Pisters LL. Surgery for Locally Advanced Disease. In: Current Urology Reports. Current Science Inc, 209-216, 2006.
16. Leibovici, D, Pisters, LL. Cryotherapy as salvage therapy for prostate cancer, 881-886, 2005.
17. Rosser CJ, Tanaka N, Stafford RJ, Price RE, Hazle JD, Tanaka M, Kamat AM, Pisters LL. Feasibility to delineate distribution of solution injected intraprostatic using an ex-vivo canine model. In: Gene Therapy and Molecular Biology. Gene Therapy Press, 509-514, 2005.
18. Pisters, LL. Editorial commentary, 278-281, 2004.
19. Mian B Pisters LL. Treatment of locally recurrent prostate cancer. In: Urology, Pearls of Wisdom. Boston Medical Publishing Corp, 282-287, 2001.
20. Scott S Pisters LL. Genitourinary cancers. In: Primary Care Oncology. W. B. Saunders, 157-174, 1999.
21. Dinney CPN, Pisters LL, von Eschenbach AC. Cryo-ablation for prostate cancer. In: Comprehensive Textbook of Genitourinary Oncology. Williams & Wilkins, 828-837, 1998.
22. Greene G, Pisters LL, von Eschenbach AC. Cryoablation of prostate cancer. In: Topics in Clinical Urology--Techniques for Ablation of Benign and Malignant Prostate Tissue. Algaku-Shoin, 189-206, 1996.
23. Pisters LL, Waisman Z. Salvage surgery following full-dose radiation therapy for prostate cancer. In: Atlas of Surgical Oncology. W. B. Saunders Company, 605-615 (Chapter 21), 1995.
24. von Eschenbach AC Pisters LL. Current surgical techniques in urology. In: Current Surgical Techniques in Urology. Medical Publications, Inc, 1995.
25. Pisters LL von Eschenbach AC. Cryoablation for prostate cancer. In: Advances in Urology. Mosby Year Book, Inc, 97-116, 1995.
26. Pisters LL Cohen MS. Reoperation for extrinsic ureteral obstruction (including retroperitoneal fibrosis) . In: Reoperative Urology. Little, Brown and Co, 75-86 (Chapter 9), 1995.
27. Pisters LL Wajsman Z. Surgery for invasive bladder cancer. In: Cancer Surgery. Lippincott, 673-694, 1993.
28. Pisters LL, Hsieh JT, Bandyk MG, Zhau HE, Johnson DE. The molecular analysis of extracellular matrix associated gene expression in mouse skin treated with an 830 nm low power laser. In: Laser Applications in Medicine and Surgery. Monduzzi Editore, 171-174, 1992.

Letters to the Editor

1. Pisters LL. Does Medical Education Need Radical Surgery, and What Kind?. The Wall Street Journal CCLXII: A12, 2013.
2. Lawrence, G, Crawford, J, Pollack, A, Taylor, N, Kelly, JF, Kuban, DA, Pisters, LL. Systemic benefit of local radiation therapy [3] (multiple letters). International Journal of Radiation Oncology Biology Physics 57: 1510-1511, 2003.